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Abstract
Vitamin B12 (later B12) intake is insufficient in developing countries, and globally, vegetarians and vegans
are also at risk of B12 deficiency. Occurring naturally only in foods of animal origin, new affordable and
sustainable dietary sources of B12 are needed to ensure sufficient intake. The only known food-grade
producers of active B12, Propionibacterium freudenreichii strains, however, are yet to be exploited to enrich
plant-based foods with B12. The B12 production capacity of P. freudenreichii depends on the strain, and the
availability of the B12 lower ligand (5,6-dimethylbenzimidazole, DMBI) is a key factor for the production
of active B12. Bread can be considered as a potential food for B12 fortification; yet the stability of in situ-
produced B12 incorporated during breadmaking processes is not known. Current analytical methods such as
the microbiological assay (MBA) lack the required specificity and the existing high-performance liquid
chromatography (HPLC) methods are only capable of measuring higher B12 levels in fortified foods and
supplements. The determination of active B12 in fermented foods, however, needs sensitive and selective
methods.
An ultra-HPLC (UHPLC) method was developed and validated to measure the active B12 contents. The
identity of the B12 form was confirmed with an ion-trap or quadrupole time-of-flight mass spectrometry
(MS). The B12 production capacity of 27 P. freudenreichii and 3 Propionibacterium acidipropionici strains
was first studied in whey-based medium (WBM), and three of these P. freudenreichii strains were chosen to
study B12 production in three aqueous cereal matrices prepared from malted barley (BM; 33% w/v), barley
flour (BF; 6% w/v) and wheat aleurone (AM). Riboflavin (RF) and nicotinamide (NAM) as food-grade
replacements for DMBI were investigated in WBM and cereal matrices. The stability of in situ-produced
B12 and added cyanocobalamin (CNCbl) and hydroxocobalamin (OHCbl) during straight-dough, sponge-
dough and sourdough breadmaking was studied.
The developed UHPLC method employing an Acquity high-strength silica (HSS) T3 column showed
excellent separation of active B12 from its analogues. A low limit of detection (0.075 ng/inj) enabled the
measurement of the B12 levels in cell extracts directly and following immunoaffinity purification in extracts
of fermented cereal matrices and B12-fortified baking samples. Analysis with UHPLC–MS confirmed the
production of active B12 by all 27 P. freudenreichii strains in WBM and 3 P. freudenreichii strains in cereal
matrices. P. acidipropionici strains, however, produced an inactive form (pseudovitamin B12), thus making
them unsuitable for active B12 fortification in foods.
The level of B12 production in WBM varied considerably between the strains (0.45௅3.35 μg/mL), which
increased up to 4-fold in 12 of the 27 P. freudenreichii strains following supplementation with RF and NAM.
In many of these strains, the B12 yield was higher with RF and NAM co-supplementation than with DMBI.
In cereal matrices without supplementation, the produced levels of active B12 (9௅37 ng/g) with P.
freudenreichii strains were nutritionally significant. The B12 production increased many-fold, reaching up
to 430 ng/g in BM, 39 ng/g in BF and 114 ng/g by adding cobalt (Co) and reached 712 ng/g in BM and 180
ng/g in AM with RF and NAM co-supplementation with Co. The incorporated in situ-produced B12 was
retained during straight-dough breadmaking and the loss of 29% during sourdough baking was similar to the
losses observed for relatively stable CNCbl. However, the added OHCbl decreased by 21%, 31% and 44%
respectively in straight-dough, sponge-dough and sourdough breadmaking. These results showed that B12
produced in situ and incorporated during breadmaking was well retained in the bread prepared by the
conventional breadmaking processes.
This thesis shows that UHPLC combined with MS allows for the accurate identification and quantitation of
low levels of active B12 in fermented food matrices (1 ng/g). P. freudenreichii strains could be utilised for
in situ production of active B12 in cereal matrices and WBM. The availability of RF and NAM could
considerably improve B12 production. The produced levels could easily fulfil the recommended dietary
allowance set for B12 (e.g. 2௅2.4 μg/day for adults), and could be well retained in bread in the commonly
used breadmaking processes.
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1 Introduction
In nature, vitamin B12 (hereafter B12) is synthesised by only a few bacteria and algae (Martens
et al. 2002). The natural occurrence of B12 is thus restricted to foods of animal origin (meat,
fish, eggs and dairy products) obtained either from their feed or due to gut microbial activities
(Martens et al. 2002; Truswell 2007; Watanabe et al. 2014). Some plant-based products may
contain a certain amount of B12 if processed with microorganisms capable of synthesising B12
(Watanabe et al. 2013). This selective natural distribution of B12 only in foods of animal origin,
unlike other vitamins, exposes certain population groups, such as vegetarians and vegans, to a
higher risk of B12 deficiency (Sych et al. 2016). The B12 intake is lower than the recommended
dietary allowance (2௅2.4 μg/d) in the lower income countries due to limited access to animal-
based foods or avoidance for religious or ethical reasons (Allen 2009; Sych et al. 2016).
Fortification is one way to address such B12 deficiencies (Pawlak et al. 2013); however, in situ
B12 production via the fermentation of plant-based foods is a sustainable and attractive way to
ensure sufficient dietary B12 intake.
B12 is an active cobamide for humans with 5,6-dimethylbenzimidazole (DMBI) as the lower
ligand. Several other cobamides with a structure identical to B12 but with a different lower
ligand are synthesised by microorganisms and are defined as B12 analogues. The DMBI ligand
of B12 is essential for its absorption and bioactivity in humans (Stupperich and Nexø 1991).
The inactive B12 analogues, however, function as the cofactor for B12-dependent enzymes in
many microorganisms (Herbert 1988; Taga and Walker 2008). The microbiological assay
(MBA), the commonly used B12 reference method of the AOAC (2006), uses the cobamide-
dependent growth of the assay organism Lactobacillus delbrueckii ATCC 7830. MBA thus
measures active B12 as well as inactive forms that support the growth of the assay organism
(Watanabe et al. 2013). However, analytical methods for measuring B12 in fermented foods
and microbial materials need to distinguish the active forms from the inactive analogues and to
be sensitive enough to be able to measure the low B12 levels encountered in food products (Ball
2006). The ultra-high performance liquid chromatography (UHPLC) and liquid
chromatography-mass spectrometry (LC–MS) methods could prove useful for the accurate
identification and selective quantitation of active B12 in foods, particularly in fermented food
matrices.
Plant-based foods are often fermented with lactic acid bacteria to enrich them with vitamins,
including B12 (Denter and Bisping 1994; LeBlanc et al. 2010; Hugenholtz 2013). So far, lactic
acid bacteria (e.g. Lactobacillus reuteri) have not been shown to produce active B12 (Santos et
al. 2007; Hazra et al. 2013; Hugenholtz 2013). However, the Emmental cheese starter
Propionibacterium freudenreichii from Propionibacteria (PAB) is known to synthesise active
B12 (Hugenschmidt et al. 2011; Thierry et al. 2011). For a long time, the biosynthesis of DMBI
in the aerotolerant P. freudenreichii was not completely understood. Deptula et al. (2015)
recently showed that the enzyme BluB/CobT2 is responsible for the biosynthesis of DMBI in
P. freudenreichii from reduced flavin mononucleotide (FMN). The in vivo experiments
confirmed that DMBI synthesis in P. freudenreichii requires oxygen (Deptula et al. 2015), as
in aerobic microorganisms (Martens et al. 2002; Taga et al. 2007), leading to the production of
the  active  forms  of  B12.  In  commercial  production,  DMBI  is  added  to  increase  B12  yields
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(Martens et al. 2002); however, DMBI supplementation is not possible in food fermentation.
The  use  of P. freudenreichii for in situ B12 fortification in plant-based foods, however, is
limited.
Previous studies had shown that riboflavin (RF) is the precursor of DMBI biosynthesis in P.
freudenreichii (Renz 1970; Lingens et al. 1992) and niacin stimulates its transformation into
DMBI (Hörig and Renz 1980). Providing RF and niacin either as supplements or food
ingredients rich in these vitamins could be natural alternatives to DMBI for improving in situ
B12 production. However, the natural PAB strains differ in B12 production  (Hugenschmidt et
al. 2010) and their response to RF and niacin is not known. The novel use of cereal matrices for
active B12 in situ fortification using P. freudenreichii requires the selection of a proper strain
and knowledge regarding the effect of key precursors that are supplemented or naturally present
in the matrices during B12 production. Besides, knowledge on the stability of the in situ
synthesised B12 in food matrices for their potential use in food applications, such as
breadmaking, is lacking.
In this thesis, a detailed review of the literature is presented on active B12 and its inactive
analogues in foods, the microbial biosynthesis of B12, fermentation fortification and the
analytical challenges involved. The methods and results of the experimental works reported in
the four papers (Studies I௅IV) are summarised. The development of UHPLC and mass
spectrometry (MS) methods for B12 analysis and the improved B12 production by PAB strains
with RF and nicotinamide (NAM) as potential food-grade substituents of DMBI are discussed.
The suitability of cereal matrices for in situ active B12 fortification with selected P.
freudenreichii strains and the stability of B12 (added or in situ-produced) in three breadmaking
processes is evaluated.
2 Review of the literature
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2 Review of the literature
2.1 Vitamin B12
2.1.1 Structure
Vitamin B12 (hereafter B12) is a general term used to define four cobamides with a common
lower ligand of 5,6-dimethylbenzimidazole (DMBI) in the Į-position and one of four upper
ligands (adenosyl, methyl, hydroxo or cyano) in the ȕ-position (Figure 1); respectively called
adenosylcobalamin (AdoCbl), methylcobalamin (MeCbl), hydroxocobalamin (OHCbl) and
cyanocobalamin (CNCbl). A central cobalt (Co) atom coordinates the four pyrrole rings, with
the lower ligand connected by a phosphate–sugar bond and the upper ligand as a metal–carbon
bond (Figure 1). AdoCbl and MeCbl are the coenzyme forms required for the activity of the
two enzymes methionine synthase and methylmalonyl-CoA (Pawlak et al. 2013). OHCbl is
formed when B12 compounds are exposed to light (Juzeniene and Nizauskaite 2013; Green and
Miller 2014), whereas CNCbl is the commercial form used in vitamin supplements and fortified
foods prepared via a reaction with cyanide during industrial manufacture (Martens et al. 2002;
Sych et al. 2016). OHCbl and CNCbl, however, are equally absorbed similarly to the coenzyme
forms and are converted into the biological forms in humans (Vorobjeva 1999; Obeid et al.
2015).
Figure 1. Structure of vitamin B12 with the lower ligand of 5,6-dimethylbenzimidazole (DMBI) and the upper
ligand consisting of either a 5ƍ-deoxyadenosyl, methyl, hydroxyl or cyano group, with their respective names being
adenosylcobalamin (AdoCbl), methylcobalamin (MeCbl), hydroxocobalamin (OHCbl) and cyanocobalamin
(CNCbl).
2.1.2 Metabolic functions
It took another four decades to confirm the actual structure of the unknown substance in pig
liver (B12) which in the 1920s was used to treat pernicious anaemia (Green and Miller 2014).
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Biochemical studies confirmed that B12 is required for the activity of only two enzymes in
humans: methionine synthase and methylmalonyl-CoA mutase (Truswell 2007; Nielsen et al.
2012). As shown in Figure 2, MeCbl is involved in methylation of homocysteine to methionine
by transferring the methyl group from 5-methyl tetrahydrofolate and is also involved in the
biosynthesis of DNA (Nielsen et al. 2012; Green and Miller 2014). AdoCbl acts as a cofactor
for methylmalonyl-CoA mutase which is responsible for the formation of succinyl-CoA from
methylmalonyl-CoA and is involved in the metabolism of odd-chain-length fatty acids and
certain branched-chain amino acids (Roth et al. 1996). The methylation reaction is linked to
folate metabolism (Figure 2). B12 deficiency thus affects the synthesis of methionine and de
novo synthesis  of  DNA  and  RNA.  A  lack  of  either  B12  or  folate  is  responsible  for  the
development of megaloblastic anaemia due to defective DNA synthesis and of other associated
disorders (Selhub and Paul 2011).
Figure 2. The cofactor functions of methylcobalamin (MeCbl) and adenosylcobalamin (AdoCbl) in humans
(adopted from Nielsen et al. 2012).
2.1.3 Active B12 and B12 analogues: Bioactivity in humans
The molecules with a corrinoid B12 structure (Figure 1) are called cobamides. The cobamides
share an otherwise identical molecular structure but differ in the lower ligand. In nature, several
cobamides are found as a result of microbial activities (Renz 1999; Sych et al. 2016). Humans
and animals are only able to absorb cobamides with DMBI as the lower ligand (Stupperich and
Nexø 1991; Roth et al. 1996), whereas cobamides with non-DMBI lower ligands are also
bioavailable to microorganisms (Taga and Walker 2008; Crofts et al. 2013). To make the
distinction clear between human-active and non-human-active B12 compounds, cobamides
with a lower ligand other than DMBI are called B12 analogues or biologically inactive B12
(Renz 1999; Watanabe et al. 2013). In the B12 analogues synthesised by many microorganisms,
the DMBI of active B12 is substituted by e.g. other benzimidazoles, purines or phenolic
compounds, as shown in Figure 3 (Renz 1999; Girard et al. 2009; Crofts et al. 2013).
2 Review of the literature
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Figure 3. Example of the lower ligands present in the cobamides synthesised by microorganisms.
One of the frequently encountered B12 analogues is pseudovitamin B12 (adenylcobamide) that
has adenine as its lower ligand. Pseudovitamin B12 is produced by L. reuteri (Santos  et  al.
2007; Molina et al. 2012), even when grown with DMBI supplementation. Salmonella
typhimurium, on the other hand, produces pseudovitamin B12 and 2-methyladenylcobamide
under anaerobic growth conditions but synthesises active B12 under aerobic conditions (Keck
and Renz 2000). PAB produce active B12 as well as inactive forms depending on the species
and the incubation conditions (Quesada-Chanto et al. 1998b; Renz 1999; Vorobjeva 1999). For
example, P. freudenreichii under aerobic growth produces active B12 whereas it also
synthesises a low level of pseudovitamin B12 under anaerobic incubation (Deptula et al. 2015).
Propionibacterium acidipropionici lacks the gene responsible for the biosynthesis of DMBI
(Parizzi  et  al.  2012),  thus  it  probably  synthesises  inactive  forms  in  the  absence  of  DMBI.
Therefore, the analysis of B12 requires the use of appropriate methods that are able to
distinguish the active forms from the inactive analogues.
2.3 B12 contents in foods
The distribution of B12 in foods is restricted to foods of animal origin (Table 1). Meat, fish,
milk, and their products are therefore the main sources of B12 in human diets. The highest B12
content is found in liver (e.g., beef liver 83.1 μg/100 g), whereas the level of B12 in chicken
(0.22 μg/100 g) is considerably lower compared to other meats (Stabler and Allen 2004; Ball
2006). Foods of plant origin are lacking in B12 unless contaminated or processed with B12-
synthesising microorganisms (Watanabe et al. 2014). For example, tempeh contains
approximately 0.18௅8 μg/100 g of B12 (Watanabe 2007) and some mushrooms may contain
traces of B12 (Koyyalamudi et al. 2009; Watanabe et al. 2012). Some edible algae – chlorella
and spirulina – are reported to contain B12 levels of 30௅200 μg/100 g dry weight (Watanabe
16
2007). However, in some algal products, up to 95% of the reported B12 values come from
human-inactive B12 analogues such as pseudovitamin B12 (Watanabe et al. 2002; Stabler and
Allen 2004; Miyamoto et al. 2006).
Table 1. B12 contents in selected foods and edible algal products (adopted from Stabler and Allen (2004), Ball
(2006) and Watanabe et al. (2014)).
Food types Food B12, μg/100 g
Meat Beef liver 83
Beef 2.6
Lamb 3.0
Goat 1.2
Pork 0.8
Chicken 0.20
Milk and milk products Cow milk 0.4
Yoghurt 0.6
Cheese 2.9
Egg 1.3
Fish and shellfish Fish 2.1௅9.6
Clams 96
Oysters 18.7
Shrimp 1.5
Fermented plant foods Tempeh 0.2௅6.3
Algal products Dried purple laver (nori) 55௅71*
Chlorella and spirulina‡ 30௅200*
 Others Fermented tea Trace
Mushroom Trace
* Dry weight basis ‡ contains mostly inactive pseudovitamin B12.
2.4 Dietary intake levels and the current B12 deficiency status
The average intake of B12 in developed countries is well above the recommended dietary
allowance (RDA) of 2௅2.4 μg/d (Stabler and Allen 2004). For example, the median intake of
3.5௅5.0 μg/d in the United States (Institute of Medicine 1998) was lower than that of 5.7௅8.0
μg/d in the Nordic countries (Nordic Nutrition Recommendations 2012 2013). Due to the
inadequate consumption of animal products, the estimated intake of B12 is below the RDA in
developing countries (Allen 2009). The intake levels are well reflected in the B12 status of the
populations globally. Only <6% of the UK and US population below 60 years of age were B12
deficient compared to 40% of children and adults in Latin America and 70௅80% in
schoolchildren and adults in Africa and India (Allen 2009). Globally, vegetarians and vegans
are often at risk of B12 deficiency (WHO 2008); the prevalence, however, is relatively low in
developed countries due to the intake of B12 supplements or fortified foods (Stabler and Allen
2004; Elorinne et al. 2016). Besides, pregnant or lactating women, infants and young children
with a low B12 intake are susceptible to B12 deficiency (WHO 2008). Despite an adequate
intake, B12 deficiency is found in the elderly due to malabsorption of food-bound B12 and also
in people with pernicious anaemia (Nielsen et al. 2012).
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2.5 Analysis of B12 in foods
The measurement of B12 in food products is problematic for two main reasons: one, its low
concentration in non-fortified foods and two, the possible inclusion of B12 analogues when
measured with non-specific methods (Stabler and Allen 2004; Ball 2006). In addition, the non-
cyano forms of B12 are sensitive to light, thus complicating the accurate quantification of the
individual forms (Kumar et al. 2010). As CNCbl is relatively stable, the native B12 compounds
in samples are converted into CNCbl by heat extraction with cyanide (Ball 2006). The universal
tool for B12 measurement, the MBA developed in the 1950s, was based on the growth of L.
delbrueckii ATCC 7830 (previously known as L. leichmannii) in proportion to the amount of
B12 in the sample extract (Hoffmann et al. 1949; Skeggs et al. 1950; Emery et al. 1951; Ford
1952; Ford 1953). Alongside MBA, colorimetric and spectrophotometric methods were also
used for the analysis of B12 in food and microbial materials (Fisher 1953; Shaw and Bessell
1960). In the last three decades, several chromatographic methods utilising different detection
techniques in combination with improved sample preparations have been developed and are
being increasingly applied for B12 analysis (Ball 2006; Kumar et al. 2010; Green and Miller
2014). Although modern liquid chromatographic methods are more selective, MBA is still one
of the most sensitive methods (detection limit: 1௅20 pg/mL) for B12 quantification (Kumar et
al. 2010; Sych et al. 2016) and is an official method recommended by the AOAC (2006). Recent
advances in liquid chromatographic separation, e.g. UHPLC (Swartz 2005) and sample
purification using immunoaffinity columns (Heudi et al. 2006; Marley et al. 2009; ùenyuva and
Gilbert 2010) have considerably improved the analytical sensitivity of the LC-based methods.
2.5.1 Microbiological assay
MBA has been in use for over 60 years as an official method for the analysis of B12. Significant
improvements have been achieved during this period; the assay is relatively simple and takes a
shorter time than the traditional method did. The early assays were performed in test tubes (Ball
2006); the introduction of 96-well microtiter plates made the assay faster with lower operating
costs (Kelleher and Broin 1991). These days, MBA is performed essentially on microtiter plates
(Kumar et al. 2010; Guggisberg et al. 2012) and serves as a reference method while developing
modern analytical methods for B12 analysis.
One major drawback of MBA is its poor specificity: the test organism L. delbrueckii 7830 not
only grows with active B12 forms but also with the B12 analogues and nucleic acids (Berman
et al. 1956; Ball 2006). B12 MBA measurements of animal-based foods would be appropriate
because  they  mostly  contain  active  B12;  however,  using  MBA  for  the  analysis  of  B12  in
samples of microbiological origin could be problematic. Taranto et al. (2003), using MBA,
reported that L. reuteri CRL1098 was the first lactic acid bacteria to produce B12 (50 ng/mL),
but it turned out to be pseudovitamin B12 (Santos et al. 2007), the inactive B12 analogue in
humans. In some shellfish and spirulina tablets, the B12 content obtained by MBA was
approximately 6௅8-fold greater than that detected with the chemiluminescence method
(Watanabe et al. 1998), probably due to the contribution from B12 analogues. Up to 2.2-fold
higher B12 contents were obtained by MBA than by HPLC when a range of meat products was
analysed by Guggisberg et al. (2012). In general, in foods analysed by MBA, B12 analogues
could represent about 5௅30% of the reported B12 contents (Ball 2006). The poor specificity of
MBA thus needs to be taken into consideration when analysing B12 from food samples that
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likely contain B12 analogues or are processed with microorganisms. Methods that are more
selective could be utilised to confirm any discrepancy in the results obtained by MBA.
2.5.2 Liquid chromatographic methods (High-performance liquid chromatography and
ultra-high performance liquid chromatography)
HPLC techniques are gradually being adopted for the analysis of B12 in fortified foods, infant
formula and vitamin supplements (Heudi et al. 2006; Campos-Giাenez et al. 2008; Marley et
al. 2009; Chen et al. 2010). Apart from fortified foods, they have also been used for measuring
B12 contents in meat (Kelly et al. 2005; Guggisberg et al. 2012; Szterk et al. 2012) and dairy
products (Van Wyk and Britz 2010). The popularity of chromatographic methods led to a few
HPLC-based methods for B12 analysis (Schimpf et al. 2012; Giménez 2014) being recently
proposed as the official methods of the AOAC. Table 1 shows the currently used
chromatographic methods with detection techniques to analyse B12 in a range of food samples.
Table 2. Liquid chromatography (LC) methods developed for B12 analysis in fortified and non-fortified foods.
Method Sample types LOD (LOQ) Reference
HPLC–UV Breakfast cereals, cereal bars, infant cereals,
cocoa beverages, milk- and soy-based infant
formulas, clinical nutrition products, skim
milk powder, acid whey powder and
polyvitamin premixes
1 (3) ng/g Campos-Giাenez
et al. 2008
HPLC–ESI–MS Infant milk powders and multivitamin-
multimineral tablets
2 ng/g Luo et al. 2006
UHPLC–MS Fortified milk powders and rice powders 6 (19) ng/mL Lu et al. 2008
HPLC–UV/Vis: on-
line sample clean
up
Multivitamin dietary supplements 3.3 (10) ng/inj Chen et al. 2010
HPLC–UV Fermented dairy products and cultures of
PAB
5 ng/mL Van Wyk and
Britz 2010
HPLC–UV:
Immunoaffinity
purification
Meat products 2 (7) ng/g Guggisberg et al.
2012
HPLC–UV:
Immunoaffinity
clean-up
NIST SRM, whey-based infant formula,
high protein powdered drinks and bars,
wheat breakfast cereal, carbonated soft
drinks, fruit juices and B12 tablets
1.5 (5) ng/inj Marley et al. 2009
HPLC–UV:
Immunoaffinity
extraction
Milk-based infant formula powder, infant
cereals with fruits and milk, breakfast
cereals, polyvitaminated mixes, petfood and
health care products
3 (10) ng/mL Heudi et al. 2006
HPLC–MS: SPE Raw beef products 0.1 ng/20 μL inj Szterk et al. 2012
HPLC–UV:
Immunoaffinity
purification
Infant formula and adult nutritionals 10 ng/mL Kirchner et al.
2012
LOD = limit of detection; LOQ = limit of quantitation. The values are given as reported in the studies.
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Almost all HPLC methods for B12 analysis are based on reverse-phase chromatography using
a column packed with C18 particles and the aqueous mobile phase consisting of either
acetonitrile or methanol operated in an isocratic or gradient mode (Kumar et al. 2010). The
detection is performed with a UV detector or photodiode array (PDA) set at a range of 361௅372
nm, with 361 nm being the commonly used wavelength for detection of CNCbl. Pakin et al.
(2005) used an HPLC method based on fluorescence detection after B12 was purified from food
samples and chemically converted into the fluorescent compound Į-ribazole. With this
technique, the quantitation limit was improved to 3 ng/g; the method, however, is time
consuming.
The HPLC–UV methods are not able to quantify the very low concentrations of B12 in non-
supplemented foods due to poor sensitivity and selectivity (Gentili and Caretti 2013). However,
the introduction of immunoaffinity purification simultaneously allows for the removal of
interfering substances from the sample extracts and the concentration of the analyte in the
fortified samples (Marley et al. 2009; Guggisberg et al. 2012; Giménez 2014). The quantitation
limits of the reported HPLC methods range from 3௅10 ng/mL or g of sample (Table 2) with
large sample sizes needed for the analysis.
The better sensitivity and efficiency offered by UHPLC technology (e.g. operating under high
pressure and the use of < 2-μm particles) in terms of improved peak resolution, peak sharpness
and shorter run time (Owen et al. 2011) for analysing B12 in foods is yet to be realised. More
recently, a UHPLC method with mass spectrometric detection was developed and validated for
measuring B12 in milk and dairy products (Zironi et al. 2013). The first action HPLC AOAC
method (Campos-Giাenez et al. 2012) was later improved by applying a UHPLC system for
B12 measurement in infant formula and adult nutritionals (Giménez 2014). However, sensitive
methods using UHPLC for B12 analysis of non-fortified and fermented food materials are
needed.
2.5.3 Mass spectrometry
MS has been useful, in addition to nuclear magnetic resonance (NMR), in obtaining the
structural confirmation of B12 and its analogues (Santos et al. 2007; Crofts et al. 2013; Deptula
et al. 2015). It is simple and easier to operate than NMR and can be conveniently interfaced
with  the  existing  LC system.  More  importantly,  MS supplements  the  LC–ultraviolet-visible
spectroscopy (LC–UV/Vis) identification, and it is useful when the standard compounds are
not commercially available. MS detection has also been applied for the quantitation of B12 in
dairy products (Zironi et al. 2014) and fortified foods (Lu et al. 2008). However, MS is widely
used for identification purposes rather than for quantitation.
The commonly used mass spectrometers for the B12 analysis of foods and microbial samples
employ electrospray ionization in the positive ion mode with triple quadrupole, time-of-flight
or ion-trap detection techniques. Koyyalamudi et al. (2009) applied quadrupole MS for the
identification of the corrinoid in cultivated mushrooms through a comparison with the B12
compounds in foods known to contain active B12 such as beef, salmon, eggs and milk. The
level of B12 in milk and milk products was measured using a triple quadrupole mass
spectrometer connected to a UPLC system (Zironi et al. 2014). The same technique was used
by Santos et al. (2007) to identify the type of B12 compound (pseudovitamin B12) in the cells
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of L. reuteri. MS with an ion trap combined with time-of-flight detectors has been used for the
identification of active B12 and/or analogues of B12 (e.g. pseudovitamin B12) in the cell
biomass of the edible cyanobacterium Nostochopsis sp. (Hashimoto et al. 2012), shellfish (Teng
et al. 2015) and CNCbl-enriched lettuce (Bito et al. 2013).
2.5.4 Other methods
Besides the MBA and LC-based methods, alternative techniques that are available for B12
determination are described in detail in a review by Kumar et al. (2010). They include the
traditional spectrophotometric methods, protein-binding assays using the intrinsic factor or
B12-specific antibodies, and the chemiluminescence method that is based on the reaction of Co
(from B12) with the assay reagent complex luminol–hydrogen peroxide. With these methods,
although some of them are sensitive, their low specificity remains a serious drawback. For
example, chemiluminescence is extremely sensitive, allowing B12 measurements up to the
picogram to femtogram level. The results, however, can easily be skewed by other metal-
containing compounds such as inactive B12 analogues (Kumar et al. 2010). The assay results
based on binding proteins can also be affected by the interaction of the binding factors with
food proteins (Sych et al. 2016). Nevertheless, the modern analytical methods for measuring
the B12 contents in foods have evolved from the biochemical methods that were developed for
assessing the B12 status by analysing the B12 in the biological fluids (e.g., blood).
2.6 B12 fortification in foods by fermentation
To address B12 deficiency due to inadequate dietary intake, plant-based foods could be
potential vehicles for B12 fortification (Pawlak et al. 2013). The full benefit of a vegetarian diet
is impacted by the lack of a few key nutrients in plant-derived foods, such as B12 (Marsh et al.
2012). Therefore, it is highly recommended that vegetarians and vegans take B12-fortified
foods or supplements to avoid the consequences of a B12 deficiency (Elmadfa and Singer 2009;
Pawlak et al. 2014). The introduction of B12 in foods could be achieved by supplementing with
purified B12 compounds during food processing (Winkels et al. 2008) or via in situ production
by microorganisms capable of synthesising B12 (Keuth and Bisping 1994; Babuchowski et al.
1999; Hugenholtz and Smid 2002; Sych et al. 2016). In addition to naturally fortifying foods
with B12, fortification by fermentation provides other benefits such as improving the texture
and storage stability of the finished product (Hugenholtz et al. 2002; Tinzl-Malang et al. 2015).
The chemical production of B12 is a complicated and economically unviable process;
commercial B12 manufacturing, therefore, relies totally on biotechnological production
(Martens et al. 2002; Sych et al. 2016). Currently, manufacturing utilises genetically engineered
strains of Pseudomonas denitrificans, Bacillus megaterium and P. freudenreichii (Hugenholtz
et al. 2002; Thierry et al. 2011; Sych et al. 2016), enabling yields as high as 206 μg/mL (Martens
et al. 2002). However, B12 production in foods cannot be carried out with genetically modified
strains, and must instead use bacterial strains that are generally recognised as safe (GRAS) such
as P. freudenreichii (Hugenschmidt et al. 2010; Deptula et al. 2015; Sych et al. 2016) directly
in foods or as food ingredients after minimal processing (Hugenholtz et al. 2002). Apart from
the bacterial strains, the fermentation conditions, medium composition and the key
supplements, Co and DMBI, affect B12 production (Li et al. 2008; Burgess et al. 2009; Wang
et al. 2015).
2 Review of the literature
21
2.6.1 General B12 biosynthesis
B12 is synthesised by a limited group of bacteria and archaea (Raux et al. 2000) via two
different pathways, aerobic and anaerobic, in a complex process involving around 30 enzymatic
reactions (Martens et al. 2002; Burgess et al. 2009). The biosynthetic pathways are mostly
studied in the aerobic bacterium P. denitrificans and the anaerobic bacteria P. freudenreichii
and S. typhimurium (Roth et al. 1996). Many of the steps are common in both pathways, but
they differ in terms of oxygen requirement during corrin ring synthesis (the aerobic pathway),
the timing of Co insertion and the biosynthesis of the lower ligand DMBI (Figure 4) (Roth et
al. 1996; Warren et al. 2002). The Co is inserted during the early stage of B12 biosynthesis in
the anaerobic pathway, whereas this reaction happens after several steps in the corrin ring
formation in the oxygen-dependent pathway (Raux et al. 2000; Warren et al. 2002; Moore and
Warren 2012). In this thesis, the focus is on B12 biosynthesis by aerotolerant PAB in which the
B12 corrin ring is synthesised by the anaerobic route while the synthesis of the lower ligand
requires oxygen (Figure 4) (Martens et al. 2002; Deptula et al. 2015).
Figure 4. The key differences in the aerobic and anaerobic biosynthetic pathways of B12 (adopted from Martens
et al. 2002). The aerobic biosynthesis of 5,6-dimethylbenzimidazole (DMBI) from flavin mononucleotide (FMN)
(e.g. in Propionibacterium freudenreichii) is highlighted.
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2.6.2 B12 biosynthesis in Propionibacteria
PAB are classically divided into two groups: dairy (isolated from cheese and milk) and
cutaneous (human skin). P. freudenreichii and P. acidipropionici are the dairy PAB commonly
used in foods (Thierry et al. 2011). The species P. freudenreichii is further divided into two
subspecies (subsp. freudenreichii and subsp. shermanii) based on lactose utilisation and nitrate
reduction. However, this phenotypic division has been disputed because strains belonging to
sub-group freudenreichii are  not  always  lactose  negative  (de  Freitas  et  al.  2015). P.
freudenreichii is one of the few microorganisms, that has been extensively studied to unravel
the microbial biosynthesis of B12 (Roth et al. 1996; Warren et al. 2002).
As part of the energy production pathway from pyruvate to propionate, PAB require B12 as a
cofactor for the methylmalonyl-CoA mutase to isomerise succinyl-CoA to methylmalonyl-CoA
conversion (Vorobjeva 1999; Thierry et al. 2011). Although the biosynthesis of B12 in PAB
takes place via the anaerobic route, one of the steps in the biosynthesis of DMBI, however,
requires oxygen (Renz 1999; Hugenholtz et al. 2002; Deptula et al. 2015). Thus, the availability
of oxygen during the fermentation regulates the production of active B12 or of analogues with
a non-DMBI lower ligand (Renz 1999; Deptula et al. 2015). In PAB, the availability of DMBI
by de novo synthesis  or  external  supplementation  is  a  critical  factor  for  the  production  of
human-active B12. Only a brief summary of the key steps of B12 biosynthesis in P.
freudenreichii is presented with a focus on the biosynthesis of the lower ligand in the latter
section.
The biosynthesis of B12 deviates from other tetrapyrroles (e.g. chlorophyll, heme) from the
common precursor uroporphyrinogen III (Figure 4). After methylation to form precorrin-2,
further reactions up to the synthesis of the intermediate adenosylcobinamide – the B12 lacking
the nucleotide moiety – proceed either via an oxygen-dependent pathway or anaerobic route
(Roth et al. 1996). The aerobic pathway requires molecular oxygen to produce precorrin-4 in a
process of ring contraction, whereas Co is inserted into precorrin-2 during anaerobic B12
biosynthesis to form Co-precorrin-2 (Moore and Warren 2012). After several steps, Co is
inserted into the fully contracted corrin ring in the aerobic route. Adenosylcobinamide is the
ultimate intermediate in both pathways, which is then joined by Į-ribazole 5ƍ phosphate to
complete the biosynthesis (Figure 2). Before the final reaction takes place, adenosylcobinamide
must be activated into adenosylcobinamide-GDP (guanosine diphosphate) by the CobV or
CobS protein (Roth et al. 1996).
The biosynthesis of the nucleotide loop base DMBI (Figure 4) again differs in aerobic and
anaerobic microorganisms. The DMBI part of B12 is synthesised, depending on the
microorganisms, either aerobically (e.g. P. freudenreichii) from flavin compounds (RF, FMN,
flavin adenine dinucleotide (FAD)) or without oxygen via the anaerobic route (e.g. Eubacterium
limosum) from a combination of glycine, formate, glutamine and erythrose-4-phosphate (Hörig
et al. 1978; Warren et al. 2002). Although P. freudenreichii synthesises adenosylcobinamide
anaerobically,  the  DMBI  part  is  synthesised  via  the  aerobic  route  from  FMN  (Renz  and
Weyhenmeyer 1972; Hörig et al. 1978; Deptula et al. 2015).
2.6.3 Biosynthesis of DMBI in Propionibacterium freudenreichii
Even after a detailed understanding of B12 biosynthesis was gained, the exact mechanism for
DMBI biosynthesis remained unclear until recently. Taga et al. (2007) confirmed for the first
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time that  the single enzyme BluB was responsible for the formation of DMBI from reduced
FMN in a soil bacterium Sinorhizobium meliloti (Figure 5). This mechanism, found in aerobic
or aerotolerant microorganisms, requires molecular oxygen (Renz and Weyhenmeyer 1972;
Taga et al. 2007). Deptula et al. (2015) recently confirmed in P. freudenreichii subsp. shermanii
DSM 4902 that a fused enzyme (BluB/CobT2) carries out both the formation of DMBI and its
activation into the nucleotide (Figure 5). In Salmonella enterica, DMBI is synthesised
aerobically, but the bacterium produces pseudovitamin B12 and 2-methyladenylcobamide with
non-DMBI lower ligands during anaerobic growth (Keck and Renz 2000).
Figure 5. Aerobic biosynthesis of 5,6-dimethylbenzimidazole (DMBI) from reduced flavin mononucleotide
(FMN) (derived from riboflavin (RF), FMN or flavin adenine dinucleotide (FAD)) by the BluB enzyme (adopted
from Taga et al. 2007). BluB is fused with CobT in Propionibacterium freudenreichii, which both transforms and
activates DMBI into Į-ribazole-phosphate (Deptula et al. 2015).
Flavin compounds are the substrate for DMBI biosynthesis in P. freudenreichii in the presence
of  oxygen  and  this  was  already  shown  to  be  the  case  in  the  1970s  (Renz  1970;  Renz  and
Weyhenmeyer 1972; Hörig and Renz 1977; Hörig et al. 1978). The first direct evidence of RF
as the precursor of DMBI in P. freudenreichii was produced by Renz (1970) through studying
the incorporation of 14C-labelled RF into the B12 structure by the cell homogenates of P.
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freudenreichii during aerobic incubation. In further experiments performed with differently
labelled RF  (Renz and Weyhenmeyer 1972; Hörig and Renz 1977; Hörig et al. 1978), DMBI
was shown to be derived from RF. The biological forms of RF – FMN and FAD – were found
to be better substrates for the synthesis of DMBI than RF was; FMN being the immediate
substrate in this transformation (Hörig and Renz 1980). The exact mechanisms behind DMBI
biosynthesis in the aerobic pathway remained unclear until the discovery of the BluB protein
(Gray  and  Escalante-Semerena  2007;  Taga  et  al.  2007).  After  the  discovery  of  the
Rhodospirillum rubrum BluB homologue in the sequence of P. freudenreichii CIRM-BIA1T
(Falentin et al. 2010), Deptula et al. (2015) confirmed that a fused enzyme (BluB/CobT2)
carries out the transformation of reduced FMN into DMBI and its activation into Į-ribazole-
phosphate (Figure 5).
2.6.4 Availability and activation of the lower ligand: Production of active B12 or its
analogues
Before the final step in the biosynthesis of B12, the lower ligand is activated by the CobT
enzyme into the phosphoribosylated base through the transfer of the ribose-phosphate moiety
of nicotinate mononucleotide (NaMN) while releasing nicotinate (Maggio-Hall and Escalante-
Semerena 1999). A number of B12 analogues are synthesised by microorganisms, clearly
demonstrating that other nucleotide bases are also incorporated into adenosylcobinamide to
form alternative cobamides (Renz 1999; Taga and Walker 2008; Crofts et al. 2013). Studies of
the substrate specificity of the CobT homologues from different organisms have shown that the
CobT enzyme can activate a range of lower ligands (Crofts et al. 2013); DMBI, however, is the
preferred substrate for CobT homologues (Hazra et al. 2013). These recent findings were in
agreement with the production of either active B12 or other human-inactive forms depending
on the availability of DMBI or its de novo synthesis, for example in S. enterica (Anderson et
al. 2008; Chan et al. 2014) and P. freudenreichii (Deptula et al. 2015). A lack of DMBI could
lead to the production of pseudovitamin B12 and other analogues in P. freudenreichii
(Vorobjeva 1999; Deptula et al. 2015). The CobT homologue of the lactic acid bacteria L.
reuteri only activates adenine (Crofts et al. 2013), thus only producing pseudovitamin B12 even
when DMBI is provided (Santos et al. 2007). Therefore, the availability of the lower ligand and
the specificity of the CobT enzyme dictate the production of active or inactive B12 forms (Renz
1999; Crofts et al. 2013).
2.7 Active B12 production with food-grade Propionibacterium freudenreichii
The fact that P. freudenreichii prefers to synthesise active B12 and that other B12-synthesising
bacteria allowed for use in foods are unable to produce active B12 makes P. freudenreichii a
potential candidate for the natural enrichment of B12 in foods. However, P. freudenreichii
strains differ considerably in terms of their B12 production (Hugenschmidt et al. 2010) and the
biosynthesis of DMBI has been reported to be a key factor limiting B12 biosynthesis (Martens
et al. 2002). With insufficient DMBI, the biosynthesis could lead to the production of inactive
B12 forms or it could remain incomplete as adenosylcobinamide (Vorobjeva 1999). For
industrial B12 production, DMBI is supplemented after the first 3 days of anaerobic
fermentation and then shifted to an aerobic incubation for another 3௅4 days (Martens et al.
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2002). The early addition of DMBI has been shown to suppress growth and B12 production
(Marwaha et al. 1983). However, DMBI cannot be added to foods; B12 production in foods
needs to be undertaken with food ingredients that are permitted in food applications. As DMBI
is synthesised from RF in P. freudenreichii and its biosynthesis could be enhanced by niacin
(Hörig and Renz 1980), these food-grade DMBI alternatives can be considered for in situ B12
production in foods. Availability of these two vitamins likely enhances active B12 production
in food fermentation, possibly through enhanced biosynthesis of DMBI and its activation into
the nucleotide leading to the complete biosynthesis of active B12.
2.7.1 Riboflavin and niacin for active B12 production
The precursor of DMBI, FMN, is synthesised from RF in a single step by flavokinase (Figure
5). The genes for RF synthesis are found in P. freudenreichii (Falentin et al. 2010; Zhang et al.
2010), yet how much of the synthesised RF is dedicated to DMBI biosynthesis is not clear. RF
overproducing mutant strains have been obtained by growing the wild strains of P.
freudenreichii with roseoflavin (Burgess et al. 2006). Renz and Weyhenmeyer (1972) found
that RF is efficiently taken up by P. freudenreichii cells and utilised for DMBI biosynthesis.
The DMBI formation in P. freudenreichii was further improved when cell homogenates were
incubated with RF and a niacin vitamer, NAM (Hörig and Renz 1980). Both subsp.
freudenreichii and shermanii were able to increase the DMBI concentration in the presence of
27mM of NAM. However, subsp. shermanii produced only small amounts of DMBI without
NAM. Although the coenzyme form of niacin (NaMN) is involved in the activation of DMBI
(Figure 4) (Deptula et al. 2015), the exact mechanism behind the stimulation of DMBI
biosynthesis is not known. NAM was found to be rapidly converted into NA (Figure 6) in the
experiment by Hörig and Renz (1980), showing that NA was the actual stimulant of DMBI
biosynthesis. Chen et al. (1995) suggested that NA or NaMN (Figure 6) could be involved in
the allosteric regulation of the BluB/CobT2 enzyme responsible for DMBI biosynthesis. RF
and NAM available in foods or added as supplements possibly enhance active B12 production.
However, the effect of RF and NAM on B12 production by living P. freudenreichii cells has
not been studied previously.
Figure 6. The metabolism of niacin. NAM = nicotinamide, NA = nicotinate, NaMN = nicotinate mononucleotide.
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2.7.2 Effect of cobalt, fermentation conditions and carbon sources on B12 production
Berry and Bullerman (1966) found that a Co level of 5 μg/mL was sufficient to produce a good
level of B12 (15 μg/mL) by a P. freudenreichii strain in whey medium supplemented with yeast
extract. Higher than 5 μg/mL Co levels did not increase the yield, which was also seen in the
study by Hugenschmidt et al. (2011). However, the natural level of Co in food media is well
below this optimised level of 5 μg/mL. For example, B12 production increased by
approximately 3-fold in supplemented whey permeate medium (440 ng/mL) following 5 μg/mL
of Co addition compared to only 140 ng/mL without supplementation (Hugenschmidt et al.
2011). The Co additions increased the B12 level in tempeh production with Citrobacter freundii
or Klebsiella pneumonie by approximately 2.3-fold (Keuth and Bisping 1994).
Supplementation with Co and DMBI is standard practice to increase the B12 yields in industrial
B12 production (Burgess et al. 2009).
The B12 manufacturing process with P. freudenreichii is usually divided into two phases:
anaerobic growth (3 days) for the synthesis of adenosylcobinamide followed by 3௅4 days of
aerobic fermentation for DMBI synthesis and completion of B12 biosynthesis (Ye et al. 1996;
Martens et al. 2002). Even though P. freudenreichii is able to grow at a moderate oxygen
concentration, the production of B12, however, is considerably reduced in an aerobic
fermentation with > 80% oxygen concentration (Quesada-Chanto  et al. 1998a). Nevertheless,
oxygen is essential for DMBI biosynthesis in P. freudenreichii, which otherwise produces
inactive B12 compounds or results in accumulation of the intermediate biosynthetic products
(Vorobjeva 1999; Hugenholtz et al. 2002).
A number of carbon sources are utilised by P. freudenreichii such as lactate, glucose and lactose
(Hettinga and Reinbold 1972; Falentin et al. 2010); the lactose utilisation, however, is strain-
dependent (Loux et al. 2015). Lactate is the preferred substrate for P. freudenreichii (Piveteau
1999); it may be able to utilise fructose but cannot metabolise maltose and sucrose (Vorobjeva
1999; Loux et al. 2015). Other carbon sources which P. freudenreichii can metabolise are
mannose, glycerol, inositol and galactose (Falentin et al. 2010; Koskinen et al. 2015). On the
other hand, P. acidipropionici metabolises diverse carbon sources, including sucrose and
maltose (Parizzi et al. 2012). The main fermentation metabolites of PAB are propionate and
acetate; their relative proportion is affected by the carbon substrates and the presence of oxygen
(Piveteau 1999). An excess of propionate is inhibitory for the growth of P. freudenreichii and
B12 production (Hsu and Yang 1991; Vorobjeva 1999) and that is why the accumulated acids
are usually neutralised in commercial B12 manufacturing (Martens et al. 2002). In food
fermentation, propionate and acetate are beneficial as antifungal agents to improve the storage
period of the products (Suomalainen and Mäyrä-Makinen 1999; Vorobjeva 1999).
2.8 Potential of in situ B12 fortification in plant-based foods
Some plant-based food sources are reported to contain B12 levels ranging from a trace amount
to a nutritionally relevant level (Watanabe et al. 2013). Fermented beans such as tempeh (0.7௅
8 μg/100 g) and natto (0.1௅1.9 μg/100 g), cabbage fermented with PAB (7.2 μg/100 g),
fermented tea (0.1௅0.5 μg/ 100 g dry weight), edible algae, for example dried green and purple
lavers (133 μg/100 g dry weight) and some edible mushrooms (0.01௅2.65 μg/100 g dry weight)
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may be suitable B12-containing foods for vegetarians (Watanabe et al. 2013). In addition, B12-
enriched vegetables have been produced such as lettuce leaves produced using hydroponics
(Bito et al. 2013) and Japanese radish sprouts prepared by soaking in a 200-μg/mL B12 solution
(Sato et al. 2004). Some of the values reported for these products may include inactive B12
compounds when the analytical methods used were less specific (e.g. MBA).  Nevertheless, the
low level of B12 content in these products and their inconvenience for incorporating into one’s
daily diet shows the need for more convenient plant-based B12 food sources.
The prospect of using the lactic acid bacteria L. reuteri strains for B12 enrichment in fermented
cereal and soy-based products has been suggested in previous studies (Taranto et al. 2003;
LeBlanc et al. 2010; Capozzi et al. 2012; Molina et al. 2012; Gu et al. 2015). Taranto et al.
(2003), for the first time, reported that the lactic acid bacterium L. reuteri CRL1098 produces
B12, which in a later study (Santos et al. 2007) actually turned out to be pseudovitamin B12.
So far, L. reuteri has not been shown to produce active B12 (Santos et al. 2007; Crofts et al.
2013; Varmanen et al. 2016). Therefore, P. freudenreichii remains the only known food-grade
species to produce active B12 but it has not yet been fully exploited for in situ B12 fortification
in plant-based fermented food products. However, P. freudenreichii strains have previously
been utilised to increase the B12 content of dairy products. The B12 content of a 7-day
fermented kefir was increased from 2.2 μg/100 mL in control samples to 9.2 μg/100 mL by
incorporating P. freudenreichii cells during kefir production (Van Wyk et al. 2011).
Cereal materials are commonly fermented to improve the technological, functional and
nutritional qualities of the finished products (Salovaara and Simonson 2004). They contain
fermentable sugars and a good level of minerals and vitamins, which are needed for the growth
of the fermenting microorganisms (Salovaara and Simonson 2004). For example, the folate
content of cereal matrices was increased several-fold by fermentation with lactic acid bacteria
and yeasts (Capozzi et al. 2012; Kariluoto et al. 2014). The ability of Propionibacterium sp.
ABM 5378 to produce folate in cereal matrices (25௅40 ng/g) was demonstrated in the study by
Kariluoto et al. (2014). Although known for active B12 production, to the best of our
knowledge, the use of P. freudenreichii for in situ B12 fortification of cereal matrices has not
been previously reported. The fermentable sugars in cereals vary between 2௅5%, with rye
containing a higher level of free sugars than other cereals do (Salovaara and Simonson 2004).
Glucose or other sugars can be added to the matrices, or matrices rich in fermentable sugars
such as malted flours can be utilised for improving the growth of P. freudenreichii. Therefore,
cereal matrices could be a good medium for the in situ production of B12.
The Co content of cereals and cereal products range from < 10 up to 60 ng/g dry matter, with
whole grain flours and the bran fraction containing the highest amounts (Hokin et al. 2004;
Ekholm et al. 2007). The distribution of Co in cereal grains and other plant foods varies
according to soil factors and the plant genotypes (Kabata-Pendias and Mukherjee 2007). For
example, Egyptian wheat grains contained several-fold higher Co (160௅380 ng/g) as compared
to trace levels (1.1௅18 ng/g) in wheat grains grown in Norway and Sweden (Kabata-Pendias
and Mukherjee 2007). Likewise, Australian wheat varieties varied widely in terms of their Co
level (13௅231 ng/g). However, the availability of Co from cereal materials during aqueous
processing for B12 production is not clear.
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2.9 Stability of B12 compounds in food processes
B12 is a relatively stable vitamin if foods are stored at room temperature and protected from
light, and aqueous solutions of B12 compounds are also found to be stable during autoclaving
(120 °C/20 min) and boiling (Ball 2006). CNCbl is more stable than the coenzyme B12 forms
are. AdoCbl and MeCbl in aqueous solutions are instantly converted into OHCbl on exposure
to light (Juzeniene and Nizauskaite 2013). Even CNCbl is converted into OHCbl if it is not
protected from light. The photo-conversion does not affect the biological activity of the B12
forms as long as the reaction is limited to the alteration of the upper ligand (Sych et al. 2016).
However, OHCbl is further degraded by strong oxidising agents such as ascorbic acid, sulphite
and iron(II) salts (Ball 2006; Ahmad et al. 2014). The B12 present in raw foods is generally
stable because it  is  mostly protected from light  and usually exists  as found-forms with food
proteins (Sych et al. 2016).
Processing of foods, however, could significantly destroy the natural B12 levels. The
knowledge on the retention of B12 during different food processes is rather limited to food
preparations related to meat, milk and fish. With these products, the losses during cooking,
grilling or stir-frying were in the range of 22௅35% (Bennink and Ono 1982; Lešková et al.
2006). Czerwonka et al. (2014) found that grilling, roasting and frying beef could lead to the
loss of 28.4%, 36.2% and 48.7% of the B12 content compared to that of the raw meat,
respectively. The losses partly resulted from the release of moisture and fat from the meat
during the cooking processes. Likewise, cooked herring contained 47% less B12 after boiling
in water (5 min), 41% after steaming (9 min), 43% after frying (4 min) and 59% after grilling
(7.5 min) or microwaving (500 W; 1 min) than the original B12 content in the raw fish
(Nishioka et al. 2011). The microwaving of raw beef and pork for 6 min at 500 W resulted in
an approximate loss of 30௅40% of B12, whereas the destruction of B12 in cow milk was even
greater (48%) (Watanabe et al. 1998).
Information on the stability of added B12 compounds or microbiologically produced B12
during the preparation of plant-based foods is scarce. Studies are, however, available for the
stability of folate in baking and other cereal processes (Gujska and Majewska 2005; Anderson
et al. 2010). In a baking powder-leavened breadmaking process with added folate and CNCbl,
almost 19௅23% of the added CNCbl was lost in the baking process (Winkels et al. 2008).
Approximately 45% of the fortified CNCbl in the wheat flour was destroyed during wheat-
dough baking, as found in the wheat flour B-enrichment programme in France (Czernichow et
al. 2003). Clearly, studies on the retention of the naturally introduced B12 in food systems
during food processes and storage are needed.
3 Aims
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 3 Aims
The  main  aim  of  this  study  was  to  investigate  active  B12  fortification  in  food  matrices  by
fermentation with food-grade P. freudenreichii and to develop sensitive and selective methods
for B12 analysis.
The specific objectives were:
1. To develop UHPLC methods for sensitive and selective quantitation of active B12 and
LC–MS methods for its accurate identification (Studies I, III).
2. To study active B12 production by food-grade Propionibacteria focusing on the
availability of the lower ligand precursors (Study II).
3. To study in situ active B12 fortification in aqueous cereal matrices (Study III).
4. To study the stability of in-situ produced B12 during breadmaking (Study IV).
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4 Materials and methods
4.1 Propionibacteria strains
Altogether, 30 PAB strains (256–266; 274–292) were studied for their B12 production in whey-
based medium (WBM) in Study II (Table 3) and 3 of the P. freudenreichii strains (256, 263
and 266) were selected for B12 production in the cereal matrices prepared from barley malt
flour (BM; 33% w/v), barley flour (BF; 6% w/v) and wheat aleurone (AM; 15% w/v) in Study
III. P. freudenreichii strain 266 was the starter culture used for the fermentation of the
experimental barley and rye malt matrices in Study I, whereas the malt-extract medium (MEM)
used in the baking stability study (Study IV) was fermented with P. freudenreichii 282 (type
strain). Three of the 30 PAB strains (278—280) were P. acidipropionici species, while the rest
of the strains belonged to the species P. freudenreichii. Strains that had both probable cereal
(274௅280) and dairy (256–266 and 281–292) origins were included in this study (Table 3).
Table 3. Propionibacteria (PAB) strains (27 Propionibacterium freudenreichii and 3 Propionibacterium
acidipropionici) with their sources of isolation studied for B12 production in whey-based medium (WBM) (Study
II). The strains used in other studies are highlighted.
Dairy origins
(Valio Ltd., Helsinki,
Finland)
Cereal origins
(Polttimo Ltd., Lahti,
Finland)
Culture collection
(DSMZ, Braunschweig,
Germany)
P. freudenreichii P. freudenreichii P. freudenreichii subsp.
shermanii
DSM 4902256 (III) 283 274
257 284 275 281
258 285 276 P. freudenreichii subsp.
freudenreichii DSM 20271259 286 277
260 287 P. acidipropionici 282 (IV)
261 288 278
262 289 279
263 (III) 290 280
264 291
265 292
266* (I, III)
* Strain isolated from a cheese starter culture (Study I)
4.2 Preparation of the fermentation media
4.2.1 Whey-based medium (Study II)
WBM (pH 6.4) was prepared by following the method by Hugenschmidt et al. (2010) using
demineralised whey powder (Demi 50; Valio Ltd., Helsinki, Finland). The medium per L
contained 60 g of whey-extract, 10 g of granulated yeast extract (Merck, Darmstadt, Germany),
13 g of sodium D/L-lactate syrup (60% w/v; Sigma-Aldrich, Steinheim, Germany), 0.1 g of
Tween 80 (Sigma-Aldrich), 0.2 g of MgSO4 (Merck), 0.02 g of Mn(II)SO4 (Merck), 1 M of
potassium phosphate buffer (Merck) and 5 mg of CoCl2 (Sigma-Aldrich).
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4.2.2 Cereal matrices (Studies I, III) and malt-extract medium (Study IV)
The cereal flours were mixed in boiling MilliQ water and cooked for 2 min.  The matrices were
autoclaved (121 °C; 15 min) and then allowed to cool. Before the inoculation, the matrices were
aseptically weighed (20 g) in 50-mL Falcon tubes. A filter-sterilised (0.2 μm) solution of CoCl2
was added to the matrices (5 μg/g) studied for B12 production with added Co.
The MEM (pH 6.4) per L contained 100 g of barley malt extract (Laihian Mallas Ltd., Laihia,
Finland), 8 g of sodium D/L-lactate syrup, 5 g of tryptone (Sigma-Aldrich), 1 M of potassium
phosphate buffer and 5 mg of CoCl2. Barley malt extract and lactate syrup were dissolved in
MilliQ water, adjusted to pH 6.4 with the phosphate buffer, filled to the mark with MilliQ water
and centrifuged. The supernatant was separately autoclaved from the tryptone stock solution
(0.2 g/mL in MilliQ water) and mixed just before the fermentation experiment. A filter-
sterilised (0.2 μm) stock solution of CoCl2 was added to obtain the final medium.
4.3 Supplementation with precursors
Preliminary study (reported in this thesis)
The B12 production in WBM without and with Co supplementation was investigated with two
P. freudenreichii strains: 256 and 266. In addition, ten P. freudenreichii strains (256௅266) were
compared for their B12 production in WBM with Co and DMBI co-supplementation before
carrying out the detailed experiments reported in Study II.
Actual supplementation (Studies II, III)
RF (40 μM), the co-addition of RF and NAM (27 mM) or DMBI (100 μM) was added to WBM
(Study II) or to the cereal matrices (Study III) intended for the respective supplementation. RF
and NAM were added on day 0 based on Study II, whereas DMBI was supplemented on day 6
of the fermentation (Hugenschmidt et al. 2010). The effect of the RF and NAM co-
supplementation time (day 0, 3 and 6) on B12 production in WBM was optimised with P.
freudenreichii strains 256 and 266 (Study II).
4.4 Fermentation and monitoring
The cryopreserved (í80 °C) cultures of the strains in glycerol were transferred onto propionic
agar medium (Study II) and then incubated for 3–4 days at 30 °C under anaerobic conditions
(Anaerocult C, Merck, Germany). To perform three biological replicate fermentations for each
strain, three individual colonies were separately sub-cultured three times in WBM without
CoCl2. To prepare fermented MEM for the baking experiments in Study IV, the colonies were
propagated in MEM without CoCl2. For B12 production experiments, the final cultures were
inoculated (1%) in 20 mL of WBM (Study II), in 20 g of the cereal matrices (Study III) or in
300 mL of MEM (Study IV).
The inoculated media were incubated for 7 days at 30 °C, first for 72 h under anaerobic
conditions (Anaerocult C, Merck) and then for a further 96 h under aerobic incubation and
shaking conditions (150 rpm). To create the aerobic atmosphere, the tubes/bottles were opened
in sterile conditions and then closed again.
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The growth was monitored by measuring the optical density (600 nm; OD600) after 168 h of
incubation for WBM (Study II) and MEM (Study IV), and by counting the viable cell counts
(cfu/g) at the beginning and after the 168 h of incubation for the cereal matrices (Study III).
The pH was measured before and after the fermentation with a MeterLab pH meter (Radiometer
Analytical, Lyon, France). The B12 content of the fermented WBM was determined by
analysing the B12 content in the cell biomass that was obtained. To get the cell biomass, the
fermented WBM was centrifuged (12,000 × g; 10 min), the pellet was washed with 10 mL of
PBS buffer (pH 7.3; Oxoid, Hampshire, UK) and centrifuged once again. Fermented cereal
matrices were analysed directly to measure the B12 content. The cell biomasses, supernatant
and the fermented cereal matrices were stored at о20 °C.
4.5 B12 stability during breadmaking (IV)
The stability of B12 in breadmaking was studied for added compounds (CNCbl and OHCbl)
and B12 produced in situ in  MEM  with P. freudenreichii strain 282 under normal baking
conditions (i.e. in daylight/laboratory lighting conditions and at room temperature). The
stability was investigated for three breadmaking processes: straight-dough, sponge-dough and
sourdough baking.
4.5.1 Stability of cyanocobalamin and hydroxocobalamin
Straight- and sponge-dough baking
Straight-dough and sponge-dough breads were prepared (Study IV) from white wheat flour
(75% extraction rate) according to the recipe given in Table 4 and the process shown in the
flowchart (Figure 7). For each baking experiment, fresh CNCbl and OHCbl standard solutions
(ca. 0.20.4 mg/mL) were prepared in water under subdued light and kept protected from
exposure to light.
Table 4. Recipe for each dough replicate used for straight-dough, sponge-dough and sourdough breadmaking.
 Dough type Ingredient Weight (g) The mass ratio to flourmass (%)
Straight- or
sponge-dough Wheat flour 400 100
Tap water or fermented MEM  238 59.5
Fresh yeast 16 4
Sugar 12 3
Margarine 12 3
Salt 4 1
Sourdough Rye flour 281 100
Tap water or fermented MEM 243 86
Sourdough seed 20 7
Salt 5 1.7
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Figure 7. A simplified flow chart of the three baking processes used to study the stability of added standard
compounds and the in situ-produced B12 in the breadmaking. MEM = malt-extract medium.
The straight-dough baking was repeated three times: without added CNCbl or OHCbl (control
breads) and with added B12 compounds (fortified breads). The baking experiment was
replicated twice for sponge-dough baking. For both of these processes, the standard B12
compounds were added (ca. 0.5 mg/recipe) after the initial mixing of the ingredients and
samples were taken during the baking processes.
Sourdough baking
For the sourdough breadmaking, the B12 compounds were added before the 16-h fermentation
(Test 1) and after the fermentation to follow the effect of fermentation on the stability of CNCbl
or OHCbl (Test 2) (Figure 7). The typical sourdough baking process is shown in Figure 7. The
ingredients (Table 4) and the details of the dough preparation can be found in Study IV.
4.5.2 Stability of in situ-produced B12
Straight-dough and sourdough baking were investigated to study the stability of the in situ-
produced B12 in the MEM by P. freudenreichii (Study IV). Water in the recipe (Table 4) was
replaced by the fermented MEM before the 16-h fermentation. Two straight-dough baking
experiments were performed, in triplicates, with fermented MEM (three biological replicate
fermentations) containing low (190 ng/mL; Trial 1) and high (690 ng/mL; Trial 2) B12 contents.
1st mixing
(Wheat flour, sugar, salt and water or
fermented MEM)
2nd mixing
Moulding
(3 × 150 g)
Proofing
(90 min; 36 °C)
Baking
(20 min; 180 °C)
CNCbl or OHCbl
1st mixing
(half of flour, baker’s yeast and water)
Pre-proofing
(2 h; room temperature)
2nd mixing
Remaining ingredients were added
Moulding
(3 × 150 g)
Proofing
(90 min; 36 °C)
Baking
(20 min; 180 °C)
1st mixing
(Sourdough starter, rye flour and water
or fermented MEM)
Fermentation
(16 h; 30 °C)
2nd mixing and resting (60 min; 30 °C)
Remaining rye flour and salt were added
Moulding
(3 × 150 g)
Proofing
(30 min; 30 °C)
Baking
(70 min; 180 °C)
CNCbl or OHCbl (Trial 1)
CNCbl or OHCbl (Trial 2)
Straight-dough baking Sponge-dough baking Sourdough baking
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4.6 B12 analysis
The B12 production by PAB in WBM is reported as volumetric yield (μg/mL) or cellular B12
yield (μg/g fresh cells) after analysing the B12 contents in samples of the cell biomass that was
obtained. The B12 contents of fermented cereal matrices (wet weight basis) and bread samples
(dry matter basis) are expressed as μg/g. The reported results are averages of three replicate
fermentations, with each sample being analysed as a single replicate unless otherwise stated.
4.6.1 Extraction
B12 compounds in the cell pellets (Studies I, II, IV), fermented cereal matrices (Studies I, III),
freeze-dried baking samples (Study IV) or in the reference and experimental samples in Study
I were extracted in their cyano form by heat extraction (100 °C; 30 min) with sodium cyanide.
Cell pellets (0.1–0.2 g), fermented samples (1–5 g), baking samples (0.2–0.5 g) or BCR 487
pig liver (0.1 g) were extracted to get the final extract volume of 25 mL, according to the method
explained in Study I. For cereal samples, the sample suspensions were incubated (37 °C; 30
min) with Į-amylase (50 mg) before the heat-extraction stage. The cell extracts were directly
analysed  with  the  UHPLC  method,  whereas  other  samples  were  first  purified  in  the
immunoaffinity columns.
4.6.2 Immunoaffinity purification (Studies I, III, IV)
The B12 extract (5–15 mL) was filtered (0.45 μm; Pall, USA) and loaded onto the
immunoaffinity column (R-Biopharma; Glasgow, UK) after the buffer filling the column was
drained. After washing the column with MilliQ water (10 mL), the retentate was eluted with
methanol (3.5 mL) followed by evaporation under a stream of nitrogen at 50 °C. The residue
was recovered in 300 μL of MilliQ water and filtered (0.2 μm; Pall) into the LC vial (Waters).
4.6.3 Ultra-high performance liquid chromatography (Studies I–IV)
For B12 analysis, a Water’s Acquity UPLC system (Waters Inc.; Milford, MA, USA) with a
PDA detector (210–600 nm) was used. The chromatogram was recorded at 361 nm. The system
consisted of a binary solvent manager, an autosampler maintained at 4 °C and a column
manager operated at 30 °C. The solvent flow was a gradient mixture of MilliQ water (A) and
acetonitrile (B) containing 0.025% trifluoroacetic acid (TFA): 0௅0.5 min (95:5), 0.5௅5 min
(95:5 to 60:40), 5௅6 min (60:40) and 6௅10 min (60:40 to 95:5). The sample injection volume
was 5௅15 uL. In each sample set, a new calibration curve was obtained by injecting CNCbl
standards (0.015௅0.75 ng/μL). To prepare a CNCbl stock solution (200 μg/mL), CNCbl was
dissolved in 25% ethanol/MilliQ water and its actual concentration was confirmed by the
spectrophotometric method described by Indyk et al. (2002).
Ultra-high performance liquid chromatography method optimisation (Study I)
The effect of the solvent flow rate (0.320.50 mL/min) and the use of the reversed-phase
ethylene bridged hybrid (BEH) or high-strength silica (HSS) T3 C18 columns with identical
dimensions (2.1 × 100 mm; 1.8 μm and 1.7 μm) were compared. The columns were evaluated
for the linearity of the calibration curve, the peak resolution and height. The chromatographic
method for the selected column was evaluated for the limit of detection (LOD; signal-to-noise
ratio, S/N = 3) and quantitation (LOQ = 3 × LOD).
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Method validation (Study I)
The optimised method was validated by the recovery tests. Control rye and barley malt matrices
(n = 3; 1.5 g) in Study I were spiked with two levels of a known amount of CNCbl (17.7 ng and
53.1 ng). CNCbl was extracted, purified on an immunoaffinity column and analysed with the
optimised UHPLC method. The spiked B12 extraction buffer (17.7 ng) was also tested for
recovery following the immunoaffinity purification. The developed method was evaluated by
analysing the extract of the immunoaffinity purified reference material (BCR 487 pig liver) and
the experimental fermented matrices.
4.6.4 Mass spectrometry (Studies I?III)
In the first two studies (Studies I, II), the mass spectrometric confirmation of the active B12
and its analogues was carried out on an ion-trap mass spectrometer (Bruker Daltonics, Bremen,
Germany). In Study III, a high-resolution quadrupole time-of-flight (QTOF) mass spectrometer
(Synapt G2-Si; Waters, Milford, MA, USA) was used. The ionization technique in both
methods was an electrospray (ESI) operated in a positive ion mode interfaced to the Waters
Acquity UPLC system. The sample injection volume was 1௅2 μL. The mobile phase for MS
contained 0.1% formic acid, replacing the 0.025% TFA used in UHPLC.
In ion-trap MS (Studies I, II), the m/z scan range was 900–1400 and the protonated target ions
were isolated and fragmented (tandem mass spectrometry (MS/MS)). For the QTOF MS (Study
III), an m/z scanning range of 50–1500 was applied. Protonated doubly charged parent ions
were detected, isolated and fragmented. The instrument settings can be found in Studies I and
III.
4.6.5 Microbiological assay (Studies I, III, IV)
The unpurified sample extracts were analysed by MBA using the assay organism L. delbrueckii
ATCC 7830 and CNCbl as a calibrant on a 96-well microtiter plate (Corning, NY, USA). A
calibration curve based on the growth (turbidity measurement at 595 nm) for the calibrant
amounts (0௅8 pg/well) was used to determine the concentration of B12 in the extracts analysed
in duplicates. The reference material BCR 487 (certified B12 content: 1120 ± 90 ng/g dm) was
always included in each assay.
4.7 Analysis of other components and fermentation metabolites
4.7.1 Riboflavin (Study II)
An optimised UHPLC method based on the European standard HPLC method (EN 14152:2014)
was used to measure the RF content of the unsupplemented control and fermented WBM (Study
II). B2 vitamers were extracted as RF following the heat (100 °C; 60 min) and enzymatic (Taka-
diastase and ȕ-amylase) extraction (24 h at 37 °C). The analysis was performed on the Waters
Acquity UPLC with an Acquity BEH C18 column (2.1 mm × 100 mm; 1.7-μm particles) by
fluorescence detection (excitation 444 nm and emission 520 nm). The elution was the isocratic
flow (0.2 mL/min) of 20 mM ammonium acetate in 30% aqueous methanol.
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4.7.2 Sugars and organic acids (Studies II, III)
Lactose and lactic acid in WBM (Study II), and glucose, fructose and maltose in the cereal
matrices (Study III) were measured in the control and fermented media. The production of
propionic fermentation metabolites, propionic acid and acetic acid was determined in the
fermented samples (Studies II, III). The sugars and acids were analysed following the sample
preparation  in  a  Waters  HPLC  system  with  refractive  index  detection  for  sugars  and  UV
detection for acids (Hugenschmidt et al. 2010).
4.8 Statistical analysis
The statistical analyses were performed with SPSS versions 20í23 (IBM Inc., NY, USA) using
one-way analysis of variance (ANOVA) with a Tukey’s post hoc test whenever applicable. A
t-test was used for comparing the B12 results obtained by the UHPLC method and by MBA.
The results were considered significantly different for a p value < 0.05.
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5 Results
5.1 Optimisation and validation of the ultra-high performance liquid
chromatography method for B12 analysis (Study I)
5.1.1 Flow rate optimisation and C18 column selection
Between the tested flow rates (0.32௅0.50 mL/min), the 0.32 mL/min rate was found to be
optimum for the separation of CNCbl in both the Acquity HSS T3 and BEH columns. When
the two C18 columns were compared at the optimised flow rate (0.32 mL/min), the HSS column
was found to be superior to the BEH column for the separation of CNCbl from the standard and
the extracts of the reference material (BCR 487) and P. freudenreichii cells (Figure 8). In
general, the HSS column produced a CNCbl peak (3.27 min) with a height 1.4-fold taller than
that obtained with the BEH column (at 2.89 min) for an equal injection volume (Figure 8). On
the HSS column, the interfering peaks were well separated from the analyte peak, and the
number of theoretical plates was 2.5-fold larger and the peak resolution was better (1.80 vs
1.10) than on the BEH column. The retention of CNCbl in the HSS column was found to be
stable (3.27 ±0.02 min) throughout the study. The same HSS T3 column was used in all four
studies (Studies I–IV) included in this thesis.
Figure 8. Separation of cyanocobalamin with the high-strength silica (HSS) and ethylene bridged hybrid (BEH)
C18 columns for the cyanocobalamin standard, immunoaffinity-purified extract of pig liver and the cell extract of
Propionibacterium freudenreichii strain 266. 1 = cyanocobalamin peak on HSS column, 2 = cyanocobalamin peak
on BEH column.
5.1.2 Immunoaffinity purification and recovery tests
The cell extract of P. freudenreichii 266 did not require immunoaffinity purification; identical
chromatograms were obtained with and without purification (Figure 9). However, the extracts
of the reference material (BCR 487 pig liver) and the CNCbl-spiked control or P.
freudenreichii-fermented cereal matrices needed the immunoaffinity clean-up, as was evident
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from the chromatograms of the unpurified extracts (Figure 9). A cleaner chromatogram with a
well-separated CNCbl peak and improved analytical sensitivity was obtained by introducing
immunoaffinity purification in the sample preparation.
Figure 9. Chromatograms of unpurified and immunoaffinity-purified extracts of BCR 487 pig liver,
cyanocobalamin-spiked control malt matrix, fermented rye malt matrix and cells of Propionibacterium
freudenreichii strain 266. Peak 1 = cyanocobalamin peak.
The mean recovery of CNCbl following the extraction and the immunoaffinity purification of
the spiked-control rye matrix at two concentrations (17.7 ng and 53.1 ng/1.5 g matrix) was
approximately  95% with  a  CV of  <  5% (Table  5).  Similar  recoveries  were  obtained  for  the
spiked B12-extraction buffer with CNCbl. The results also agreed with those obtained from
MBA without the purification step (Table 5).
Table 5. Recovery of the added cyanocobalamin by microbiological assay (MBA) and by ultra-high performance
liquid chromatography (UHPLC) after immunoaffinity purification. (Study I)
Sample Spikedamount (ng) Recovery, % (RSD, %)
Day 1 Day 2
UHPLC MBA UHPLC MBA
0.0 ND ND ND ND
Rye malt matrix 17.7 97.2 (3.1)a 95.0 (0.9)a 93.8 (5.3)a 98.2 (4.3)a
53.1 96.8 (2.4)a 94.8 (3.7)a 91.2 (2.5)a 96.1 (5.7)a
Extraction
Buffer 17.7 94.6 (1.0)
a 92.7 (5.7)a 97.4 (1.9) NA
ND = Not detected; NA = Not analysed
Values with dissimilar superscript letters (a and b) along each row indicate a significant difference (p < 0.05).
The validated UHPLC method enabled a detection limit of 0.075 ng/inj (5 μL) and
quantification limit of 0.22 ng/inj. Due to the improved sensitivity of the UHPLC system and
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use of immunoaffinity purification, it was possible to analyse samples with a B12 content as
low as 1 ng/g with good reproducibility.
5.1.3 Specificity of the developed ultra-high performance liquid chromatography method
The reference material (BCR 487 pig liver) and three experimental samples (cell biomass,
fermented rye and barley matrices) were analysed to test the applicability of the validated
UHPLC  method  in  comparison  to  MBA  (Table  6).  In  pig  liver  and  the  fermented  cereal
matrices, significantly higher B12 contents (17௅37%) were obtained with MBA than were
analysed with the UHPLC method following immunoaffinity purification (p < 0.05). The B12
content of the concentrated fermented malt extract (an experimental sample prepared by
concentrating barley malt extract fermented with strains of bacteria producing lactic and
propionic acids) according to the MBA method was 1200 ng/g; however, no CNCbl was
detected when it was analysed with the UHPLC method (Table 6). Nevertheless, both methods
gave identical B12 contents in the WBM fermented with P. freudenreichii strain 266 (p >0.05).
Table 6. Analysis of B12 with the ultra-high performance liquid chromatography (UHPLC) method and the
microbiological assay (MBA) in reference material pig liver, fermented cereal matrices and the cell biomass of
Propionibacterium freudenreichii strain 266. (Study I)
Sample UHPLC (ng/g) MBA(ng/g)
UHPLC/MBA,
%
BCR 487 pig liver (n = 8) 876 (±49)a* 1056 (±80)b* 82.9
Fermented rye malt matrix (n = 2 × 2)‡ 19.3 (±1.5)a 28.8 (±2.4)b 67.0
Fermented barley malt matrix (n = 2 ×
2)‡ 15.7 (±2.4)
a 25.0 (±2.3)b 62.8
Cell mass (from fermented WBM)
 (n = 3)
620 (±90)a#
(ng/mL)
650 (±60)a#
(ng/mL)
95.4
Concentrated fermented malt-extract
(n = 3) ND 1196 ± 56 -
Values are means ± SD.
*Dry matter basis; ‡Biological replicates = 2 and analytical replicates = 2; #Expressed per unit volume of
fermented medium
WBM = Whey-based medium; ND = Not detected
Values with different superscript letters (a and b) along the row indicate a significant difference (p < 0.05)
5.2 Ultra-high performance liquid chromatography–mass spectrometry
identification of the B12 compounds
In Studies I and II, the identification of active B12 and its analogues was confirmed with the
ion-trap mass spectrometer. In Study III, a high-resolution QTOF mass spectrometer allowed
for the accurate identification of active B12 and its inactive forms in the cereal matrices
fermented with P. freudenreichii strains.
5.2.1 Ultra-high performance liquid chromatography–ion-trap mass spectrometry
(Studies I, II)
The peak eluting at 3.27 min for the CNCbl standard and the pig liver (Figure 10) produced an
ion peak in the mass chromatogram when ions with an m/z of 1356 were detected and
fragmented. The fragment ions (m/z 1209, 1124, 997, 912) were identical for the peak from the
CNCbl standard (Figure 11A) and BCR 487 (Figure 11B). However, no CNCbl peak was
detected in the immunoaffinity-purified extract of the concentrated fermented malt extract
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(Figure 10). The peak appearing at 3.16 min had an identical PDA spectrum (210௅600 nm) to
that of CNCbl. The MS/MS showed a fragment profile identical to that of CNCbl for molecular
ions with an m/z of 1345. The m/z 1345 value corresponds to the B12 analogue pseudovitamin
B12  with  adenine  as  the  lower  ligand.  On  the  other  hand,  the  WBM  fermented  with P.
freudenreichii 266, where both the UHPLC and MBA results agreed (Table 6), showed only
the CNCbl peak and mass spectra identical to those observed for the BCR 487 pig liver.
Figure 10. Ultra-high performance liquid chromatography (UHPLC) chromatograms of immunoaffinity-purified
extracts of the fermented malt extract (A), BCR 487 pig liver (B) and the cyanocobalamin standard (C). The peaks
for CNCbl (TR = 3.27 min) and pseudovitamin B12 (TR = 3.16 min) are shown. (Study I)
Figure 11. Ion-trap tandem mass spectrometry (MS/MS) of the peaks (Figure 3) eluting at 3.27 min (A;
cyanocobalamin) and at 3.16 min (B; pseudovitamin B12).
WBM fermented by 27 P. freudenreichii strains  (Table  3)  with  or  without  DMBI
supplementation contained only active B12, as shown in the example chromatograms (Figure
12A) and the mass spectra obtained with the ion-trap MS/MS (Figures 12C and D). The
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retention time, the PDA spectra (210௅600 nm) and the mass spectra of the peaks were all
identical to those of the CNCbl standard. However, the WBM fermented with three P.
acidipropionici strains did not contain any active B12. Instead, a peak appeared at 3.16 min
with the mass spectrum identical to that of pseudovitamin B12 when their cell extracts were
analysed (data not shown).
Figure 12. Ultra-high performance liquid chromatography (UHPLC) chromatograms (A), and ion-trap tandem
mass spectrometry (MS/MS) spectra of the cyanocobalamin standard (B) and the cell extracts of
Propionibacterium freudenreichii strain 256 grown in WBM without 5,6-dimethylbenzimidazole (DMBI) (C) and
with DMBI (D). (Study II)
5.2.2 Ultra-high performance liquid chromatography–quadrupole time-of-flight mass
spectrometry (Study III)
With UHPLC–QTOF MS, the B12 compounds in three types of cereal matrices fermented with
P. freudenreichii strains 256, 263 and 266 were identified. Similar to those shown in the
example  chromatograms  (Figure  13A)  and  QTOF  mass  spectra  (Figure  13C),  the  matrices
fermented with any of the three strains showed a CNCbl peak (3.27 min) in their
immunoaffinity-purified extracts. The ions of the peaks showed an m/z of 678.2882, identical
when the CNCbl standard was run, and upon MS/MS of the parent ions, produced fragment
ions having an m/z of 1209.4858, 1124.4423, 997.4788, 912.4494, 359.1023 and 147.0919
(Figure 13C). These m/z values perfectly matched with the theoretical m/z of  the  CNCbl
fragments, including protonated DMBI (m/z 147.0919), clearly showing that the fermented
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matrices contained active B12. In addition to active B12, BM supplemented with Co and
fermented with P. freudenreichii strain 256 or 266 showed an additional peak at 3.16 min
(Figure 13A) in their immunoaffinity-purified extracts. This peak was confirmed with QTOF
MS/MS to be pseudovitamin B12 (m/z 672.7752), with adenine as the lower ligand (m/z
136.0638) (Figure 13D).
Figure 13. Ultra-high performance liquid chromatography (UHPLC) chromatograms (A) and the quadrupole time-
of-flight (QTOF) tandem mass spectrometry (MS/MS) spectra of the chromatographic peaks from the
cyanocobalamin standard (B) and the extracts of the barley malt matrix (BM) fermented with Propionibacterium
freudenreichii strain 256 or 266 with supplementation of cobalt (Co), and Co together with riboflavin (RF) and
nicotinamide (NAM) (C and D). C = peak at 3.27 min and D = peak at 3.16 min. (Study III)
5.3 B12 production by Propionibacteria in whey-based medium
5.3.1 B12 production without precursor supplementation
The B12 production capacity of 30 PAB strains in WBM without precursor supplementation is
shown in Figure 14, reflecting a wide difference in the active B12 synthesis between the strains.
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The 27 P. freudenreichii strains produced a volumetric yield of B12 ranging from 0.45 μg/mL
(281) up to 3.35 μg/mL (288). The level of B12 production by P. freudenreichii strains was
reflected in the corresponding RF consumption (Figure 15). More volumetric B12 production
was achieved by a strain that also depleted the greatest amount of RF, thus producing a
significant positive correlation (p < 0.05; r = 0.84) between the consumption of RF (25௅85%)
and  production  of  B12.  However,  the  level  of  RF  was  similar  to  the  control  WBM  when
fermented with the P. acidipropionici strains 278௅280 (Figure 15), thus being in agreement
with the lack of any active B12 production in these strains (Figure 14). The growth varied
widely between the strains (OD600 1.2௅17.8) and the pH changed accordingly (4.7௅6.5) from
the initial value of 6.4 (Figure 1 in Study II).
Figure 14. B12 production by 30 Propionibacteria (PAB) strains in whey-based medium (WBM). The values are
the average of three biological replicate fermentations. The error bars represent standard deviations.
Figure 15. Riboflavin (RF) consumption vs B12 production by 30 Propionibacteria (PAB) strains in whey-based
medium (WBM). (Study II)
5.3.2 Effect of riboflavin and nicotinamide supplementation time on B12 production
Supplementation with RF and NAM on day 0 or day 3 in WBM produced 2.4-fold more B12
by P. freudenreichii strain 266 compared to its production when supplementation was carried
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out on day 6 (Figure 16). However, P. freudenreichii strain 256 did not respond to the RF and
NAM supplementation. The co-addition of RF and NAM on day 6 did not enhance B12
production compared to the production in WBM without addition (Figure 16). Interestingly, the
B12 production by strain 266 did not increase when the lower ligand DMBI was provided
compared  to  there  being  an  80%  increase  in  the  B12  yield  by  strain  256  with  DMBI
supplementation (Figure 16). Based on these results, RF and NAM were supplemented at the
beginning of the fermentation.
Figure 16. The effect of time (day 0, 3 and 6) of co-supplementing riboflavin (RF) and nicotinamide (NAM) on
B12 production in whey-based medium (WBM) by Propionibacterium freudenreichii strains 256 and 266. The
data represents the average (and standard deviation) of three biological replicate fermentations. (Study II)
5.3.3 Effect of natural precursors vs 5,6-dimethylbenzimidazole on B12 production
The response to the supplementation with DMBI or its replacement with natural precursors (RF
and NAM) on B12 production by the 30 PAB strains was strain-dependent, in terms of both the
volumetric and cellular B12 yields (Figure 17). The supplementation with RF alone did not
increase the volumetric or cellular B12 yield in any of the studied strains. However, when RF
was co-supplemented with NAM, the volumetric B12 production (μg/mL) increased
significantly up to 4.2-fold in WBM fermented with 12 of the 27 P. freudenreichii strains
(Figure 17A). The highest B12 production was achieved with strain 284 following RF and
NAM supplementation, reaching up to 4.2 μg/mL. On the other hand, the greatest enhancement
(4.2-fold) was observed for the P. freudenreichii subsp. shermanii type strain (281) following
RF and NAM supplementation, increasing the yield from 0.44 to 1.86 μg/mL. An increased
OD600 value was observed with RF and NAM supplementation in a few of these strains; the pH,
however, did not decrease (Figure 1 in Study II). However, the volumetric B12 yield with four
strains (274, 275, 276 and 286) and the P. freudenreichii subsp. freudenreichii type strain (282)
was significantly reduced by supplementation with RF and NAM (p < 0.05). In six of the non-
slime producing strains, the cellular B12 yield (μg/g wet cell mass) increased (up to 4-fold)
following RF and NAM addition (Figure 17B).
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Three strains (256, 288 and 290), which did not respond to the RF and NAM supplementation,
produced more volumetric and cellular B12 yields with DMBI (Figure 17). For four strains
(257, 281, 283 and 289), an equally enhanced B12 production was possible either with DMBI
or with co-supplementation with RF and NAM (Figure 17A and B). Interestingly, seven of the
studied strains (261௅264, 266, 284 and 285) produced significantly more B12 in WBM
following RF and NAM supplementation than they did with DMBI (Figure 17A). Three P.
acidipropionici strains (278௅280) produced a trace amount of B12 (< 0.20 μg/mL and < 15.5
μg/g cells) only with DMBI supplementation.
5.4 B12 production in cereal matrices by Propionibacterium freudenreichii strains
The B12 results presented here for cereal matrices were obtained with the UHPLC method. The
MBA results that are shown will later be compared with those from the UHPLC method in
Section 5.6.2.
5.4.1 B12 production in barley malt matrix
In BM without any added precursors, P. freudenreichii strain 256 produced 37 ng/g of active
B12, while with strains 263 and 266, the B12 yield was 12௅13 ng/g (Figure 18).
Supplementation of BM with DMBI did not improve B12 production. However, when DMBI
was added together with Co, the production increased by 40-fold in strain 256 (1480 ng/g), 86-
fold in strain 263 (943 ng/g) and 75-fold in strain 266 (1000 ng/g). The production with Co
alone, studied only with strains 256 and 266, was 10-fold higher than their respective production
levels in the basic matrices (Figure 18), and the highest production with Co was 430 ng/g in
strain 256. When DMBI was replaced with RF and NAM, the B12 yield in Co-supplemented
BM further increased compared to the production with Co only with both strains, achieving a
B12 production level of 716 ng/g by strain 256 and 627 ng/g by strain 266 (Figure 18). Despite
a large difference in B12 production, the final cell counts were similar in all of the 168-h
fermented matrices (Table 1 in Study III).
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* The ultra-high performance liquid chromatography (UHPLC) and the microbiological assay (MBA) results were
significantly different (p < 0.05).
Figure 18. B12 production by Propionibacterium freudenreichii strains (256, 263 and 266) in the malted barley
matrix (BM) without or with cobalt (Co), riboflavin (RF) and nicotinamide (NAM), or 5,6-dimethylbenzimidazole
(DMBI). The results were obtained with UHPLC and MBA and are given as averages of three biological replicate
fermentations (error bars represent standard deviations).
5.4.2 B12 production in barley flour and aleurone matrices
In BF fermented with strains 256, 263 or 266, a B12 level of ca. 9 ng/g was produced (Figure
19). As in BM, the DMBI supplementation did not enhance B12 production in BF. When DMBI
was co-supplemented with Co, the production in BF by strain 256 increased ca. 9-fold (80 ng/g)
and by 5-fold in strain 263 (47 ng/g). Supplementation of Co only improved the B12 yield in
BF up to 39 ng/g. The B12 production in basic AM was similar to that in BF. However, the B12
yield was considerably higher than in BF when AM supplemented with the precursors was
fermented with strain 256 or 266 (Figure 19). With DMBI and Co, the production of B12 in
AM by strain 266 reached 257 ng/g from 10 ng/g in basic AM (a 24-fold rise), whereas with
strain 256, the yield only increased by 10-fold (101 ng/g). With RF and NAM together with Co,
the yields were higher than that achieved only with Co addition in AM (Figure 19). However,
the supplementation did not affect the final cell counts in BF and AM (Table 1 in Study III).
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* The ultra-high performance liquid chromatography (UHPLC) and the microbiological assay (MBA) results were
significantly different (p < 0.05).
Figure 19. B12 production by Propionibacterium freudenreichii strains 256, 263 and 266 in barley flour matrix
(BF) and aleurone matrix (AM) without or with supplementation of cobalt (Co), riboflavin (RF) and nicotinamide
(NAM), or 5,6-dimethylbenzimidazole (DMBI). The results were obtained by UHPLC and MBA, and given as
averages of three biological replicate fermentations, with error bars representing the standard deviations.
5.5 Stability of B12 compounds during three breadmaking processes
The fate of added CNCbl, OHCbl or in situ-produced B12 during the breadmaking was
followed in different stages of the processes, as indicated in Figures 20 and 21 (straight- and
sponge-dough) and in Figures 20 and 22 (sourdough). Results obtained with MBA and the
UHPLC method are given; however, the stability of B12 compounds during the breadmaking
process is followed based on the results from the UHPLC method only. The MBA results are
compared in Section 5.6.3.
5.5.1 Stability of cyanocobalamin and hydroxocobalamin
Straight- and sponge-dough baking
In straight-dough baking, the added CNCbl was not affected by the 1.5-h proofing or by the
baking step (Figure 20A). In sponge-dough breadmaking, the losses can be compared only
between the first mixing and after the 2-h pre-proofing, and after the second mixing and the
remaining steps. CNCbl was also stable in the sponge-dough breadmaking process, apart from
the reduced initial level after the second mixing due to dilution by the remaining flour (Figure
20B). The additional 2-h pre-proofing step in the sponge-dough process, however, reduced the
OHCbl level by 31% (Figure 20B) as compared to only a 21% loss in the straight-dough process
(Figure 20A).
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Figure 20. Content of added CNCbl and OHCbl (μg/g, dm) in straight-dough samples (A), in sponge-dough
samples (B) and in sourdough samples (C added after 16-h fermentation; D added before 16-h fermentation)
analysed by the microbiological assay (MBA) and ultra-high performance liquid chromatography (UHPLC)
methods. Error bars represent the standard deviations of three independent baking trials (A) or the range of two
independent trials (B). Sourdough experiments were performed once. In sponge-dough baking (B) sub-samples
after 1.5-h proofing were not determined by the UHPLC method. The losses can only be compared for samples
before or after the second mixing step for B and D.
Sourdough baking
The sourdough baking decreased the contents of both the added CNCbl and OHCbl (Figures
20C and D). The total loss of CNCbl was 23% as compared to a 44% destruction of OHCbl
when these compounds were added after the 16-h fermentation (Figure 20C). The addition of
CNCbl or OHCbl before the 16-h fermentation, right at the first mixing step, did not
significantly increase the total losses during the sourdough baking (Figure 20D) when
compared to the late addition. The losses, however, can only be compared between samples
before or after the 16-h fermentation due to the dilution following addition of the remaining
flour. Overall, it was evident from Figures 20C and D that the losses in the sourdough process
happened mostly in the longer baking step (70 min at 180 °C).
5.5.2 Stability of in situ-produced B12 by Propionibacterium freudenreichii
Straight-dough baking
Both at low (Trial 1; 0.114 μg/g dm) and high (Trial 2; 3.9-fold of Trial 1) initial levels, the in
situ-produced B12 remained stable during the straight-dough breadmaking (p > 0.05; Figure
50
21). Neither the 1.5-h proofing nor the baking step (20 min at 180 °C) significantly reduced the
total B12 content.
Figure 21. B12 content of straight-dough samples (μg/g, dm) baked in fermented malt-extract medium (MEM) in
Trial 1 (low-vitamin content) and in Trial 2 (high-vitamin content) determined by the microbiological assay
(MBA) and the ultra-high performance liquid chromatography (UHPLC) methods. Error bars represent standard
deviations of three separate baking processes with three biological replicates of fermented media. Sub-samples
after 1.5-h proofing were not determined by the UHPLC method.
Sourdough baking
As with CNCbl or OHCbl, the incorporated in situ-produced B12 by P. freudenreichii in the
sourdough decreased significantly during the sourdough baking step by 29 ± 4% (Figure 22).
A slight increase in the B12 content was found after the 16-h fermentation by the UHPLC
method, in contrast to a 23% increase in the B12 level when analysed with MBA. No notable
losses of in situ-produced B12 were observed in other steps of sourdough breadmaking.
Figure 22. B12 content of sourdough samples (μg/g, dm) baked in fermented malt-extract medium (MEM) as
determined by the microbiological assay (MBA) and ultra-high performance liquid chromatography (UHPLC)
methods. Error bars represent the standard deviations of three separate baking processes with three biological
replicates of fermented media. The losses can only be compared for samples before or after the second mixing
step.
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5.6 Comparison of the B12 contents obtained by the ultra-high performance liquid
chromatography method and by microbiological assay
The B12 contents obtained with the UHPLC method following immunoaffinity purification
were compared with those obtained with MBA in the experimental samples (Study I),
fermented cereal matrices (Study II) and baking samples (Study IV). In addition, the B12
production in WBM by P. freudenreichii strains obtained using MBA and the UHPLC method
without the immunoaffinity-purification step were also evaluated (Tables 7 and 8).
5.6.1. Fermented whey-based medium (Study II and this thesis)
Table 7 shows the B12 contents in WBM produced by 10 P. freudenreichii strains (256௅266)
with added DMBI by analysing the cell  biomass with MBA and UHPLC. For all  ten strains
grown in WBM with DMBI supplementation, the MBA and UHPLC results were statistically
similar (p > 0.05) with a UHPLC to MBA ratio ranging from 90௅110%.
Table 7. B12 contents obtained by ultra-high performance liquid chromatography (UHPLC) and microbiological
assay (MBA) in the cell biomasses of 10 Propionibacterium freudenreichii strains grown in whey-based medium
(WBM) with 5,6-dimethylbenzimidazole (DMBI) supplementation. The results are given as μg/mL of WBM.
Strain UHPLCa MBAa UHPLC/MBA, %
256 1.53 (0.34) 1.45 (0.36) 105.5
257 2.39 (0.40) 2.24 (0.23) 106.7
258 1.61 (0.05) 1.56 (0.05) 103.2
259 2.18 (0.08) 2.10 (0.06) 103.8
260 1.06 (0.02) 1.08 (0.01) 98.1
261 1.26 (0.32) 1.37 (0.25) 92.0
262 0.72 (0.03) 0.79 (0.03) 91.1
263 1.58 (0.31) 1.63 (0.23) 96.9
264 1.00 (0.07) 1.00 (0.07) 100.0
265 1.07 (0.13) 0.95 (0.11) 112.6
266 0.62 (0.06) 0.61 (0.06) 101.6
a The UHPLC and MBA data along each row did not differ significantly (p > 0.05).
The UHPLC and MBA methods gave identical B12 contents (p > 0.05) in WBM fermented by
P. freudenreichii strains 256 and 266 without or with Co, and RF and NAM co-supplemented
either on day 0, 3 or 6 (Table 8).
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Table 8. B12 contents determined by ultra-high performance liquid chromatography (UHPLC) and
microbiological assay (MBA) in the cell biomasses of strains 256 and 266 grown in whey-based medium (WBM)
without cobalt (Co) and with co-addition of Co and 5,6-dimethylbenzimidazole (DMBI), or with riboflavin (RF)
and nicotinamide (NAM) on a different day (0, 3 or 6). The results are expressed as μg/mL.
Medium + supplements
256 266
UHPLC MBA UHPLC/MBA, % UHPLC MBA
UHPLC/
MBA, %
WBM without Co 0.19a
(0.01)
0.21a
(0.01)
90.5 0.24a
(0.01)
0.25a
(0.01)
96.0
WBM with Co 0.93a
(0.03)
1.11a
(0.02)
83.8 0.74a
(0.03)
0.86a
(0.01)
86.0
WBM RF+NAM (0) 1.12a
(0.08)
1.28a
(0.05)
87.5 2.20a
(0.10)
2.34a
(0.18)
94.0
WBM RF+NAM (3) 1.05a
(0.07)
1.13a
(0.04)
92.9 2.12a
(0.07)
2.20a
(0.07)
96.4
WBM RF+NAM (6) 0.8 a
(0.02)
0.88a
(0.03)
92.0 1.10a
(0.17)
1.18a
(0.04)
93.2
a The UHPLC and MBA data along each row did not differ significantly (p > 0.05).
5.6.2 Fermented cereal matrices (Studies I, III)
The B12 results from the UHPLC method for the 24-h fermented rye and barley malt matrices
with P. freudenreichii strain 266 (I) were 33௅37% lower than those obtained with MBA (Table
6).
The UHPLC and MBA results of the 7-day fermented cereal matrices with P. freudenreichii
strains 256, 263 or 266 (Study III) differed depending on the supplementation with the
precursor  (Figures  18  and  19).  In  general,  the  UHPLC  and  MBA  results  were  statistically
similar (p > 0.05) in the basic matrices as well as when DMBI or DMBI together with Co were
used as supplements. When BM was supplemented with Co, the UHPLC results of the BM
fermented with strain 256 or 266 were ca. 40% lower compared to the results obtained with
MBA (Figure 18). Likewise, the B12 contents of the fermented AM with Co supplementation
when analysed by MBA were significantly higher than the results obtained with the UHPLC
method were (p < 0.05; Figure 19). In Co-supplemented BF, both methods gave similar B12
contents. In BM or AM with RF and NAM supplementation together with Co, the B12 results
from both the MBA and UHPLC methods were identical (p > 0.05; Figures 18 and 19).
5.6.3 B12 Added or in situ-fortified samples during breadmaking (Study IV)
In the straight- and sponge-dough breadmaking with added CNCbl or OHCbl, MBA and
UHPLC gave identical B12 contents for the dough, proofed and baked samples (p > 0.05;
Figures 20A and 20B). In the sourdough baking with added CNCbl, the B12 contents obtained
by these two methods in the samples from mixing to the baking step did not differ (p >0.05).
Both methods produced similar B12 contents in OHCbl-fortified sourdough samples, except
for the doughs after a 16-h fermentation and the breads. For these samples, MBA gave 27%
higher B12 contents than the UHPLC method did (Figure 20D).
The B12 contents given by MBA for the dough and bread samples in the straight-dough
breadmaking with the fermented MEM containing in situ-produced B12 (in both Trial 1 and
Trial 2) were 11௅33% higher compared to the values from the UHPLC method (p > 0.05; Figure
21). During sourdough breadmaking with the in situ-produced B12, the B12 content of the 16-
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h fermented dough significantly increased (24 ± 14%; p < 0.05) according to MBA. In
comparison to the UHPLC results, MBA gave 33% more B12 contents in the 16-h fermented
sourdough (Figure 22). Overall, during the sourdough processes with MEM containing in situ-
produced B12, MBA resulted in 19௅47% higher B12 contents than their respective values as
determined by the UHPLC method (Figure 22).
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6 Discussion
6.1 Sensitivity and selectivity of the developed ultra-high performance liquid
chromatography method
Separation and method performance
The HSS T3 C18 column was found to be superior to the BEH C18 column for the peak
resolution, the peak sharpness and in terms of avoiding the co-elution of the analyte and the
interfering substances (Figure 7). The solvent flow rate of 0.32 mL/min in the gradient mode
(water and acetonitrile acidified with 0.025% TFA) was found to be optimum in this study and
has been previously applied for UHPLC separation of cobalamins in cell culture media (Owen
et al. 2011) and in HPLC analysis of B12 in PAB cells grown in supplemented whey permeate
(Hugenschmidt et al. 2010). The UHPLC method with immunoaffinity purification
demonstrated excellent inter-day recovery (ca. 95%) with the residual standard deviation (RSD)
being < 5% when control cereal matrices fortified with CNCbl (at two levels) were analysed
(Table 5). The stable retention of the CNCbl peak (a 30-day average of 3.27 min ± 0.02) using
the HSS T3 column throughout the study period showed the reliability and the robustness of
the developed method. A clear separation of pseudovitamin B12 (retained at 3.16 min) from
the CNCbl (at 3.27 min) enabled accurate quantitation of active B12 in the studied samples
(Studies I௅IV).
The developed and validated UHPLC method reported in Study I allowed for the quantitation
of the B12 content in a variety of samples, directly after extraction for cell biomass (Study II)
and after immunoaffinity purification for the fermented cereal matrices (Studies I and III) and
the samples from the breadmaking processes (Study IV). The considerably low quantitation
limit of 0.225 ng B12/inj made the analysis of B12 in the wet cell biomass of PAB (as low as
0.4 μg/g) possible without the immunoaffinity-purification step. Additionally, due to the lower
detection level of the UPLC system when combined with the sample clean-up and the
concentration potential provided by immunoaffinity purification, a B12 content of
approximately 1 ng/g can be measured. The detection limit of 0.075 ng/15 μL-inj by the current
method was several-fold more sensitive than the 1.5௅3.3 ng/inj reported for the HPLC–UV
methods that also required larger sample injections (50௅100 μL) (Heudi et al. 2006; Chen et al.
2009; Marley et al. 2009; Guggisberg et al. 2012). Unlike the larger samples needed for the
HPLC methods, the analysis with the current UHPLC method can be accomplished with small
samples  (<  5  g).  In  addition,  the  run  time  was  shorter  (10  min)  with  the  UHPLC  method
compared to the 30௅40 min required for analysing B12 with the HPLC methods. Furthermore,
the UHPLC method is much quicker than the time-consuming and labour-intensive MBA for
the determination of B12 in food products (Ball 2006; Sych et al. 2016).
Need and usefulness of immunoaffinity purification for B12 analysis
Analysis of B12 in the samples with less interfering substances and a detectable amount of B12,
such as washed P. freudenreichii cells, did not require immunoaffinity purification (Figure 9).
However, to analyse B12 from samples containing a low level of B12 and sample matrices as
complex as the lyophilised pig liver (BCR 487) or cereal matrices, the use of immunoaffinity
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purification not only removed the background chromatographic noise but also allowed for the
selective concentration of the analyte (Figure 9). Both the clean-up and analyte enrichment of
the sample extracts enabled the clear separation and selective quantitation of the active B12 in
the certified reference material, the fermented cereal matrices and baking samples (Studies I,
III, IV). The usefulness of introducing immunoaffinity sample preparation for HPLC
determinations of B12 was shown previously in other food matrices such as fortified foods
(Heudi et al. 2006; Marley et al. 2009) and meat products (Guggisberg et al. 2012). However,
one drawback of immunoaffinity purification is that the B12 needs to be in the cyano form, for
example CNCbl, for good recovery (Marley et al. 2009). The recovery of OHCbl was only up
to 75%, whereas the affinity of AdoCbl and MeCbl to antibodies is quite low (Marley et al.
2009). Besides, AdoCbl and MeCbl are highly unstable in light, converting instantly to OHCbl
on exposure to light. Thus, for the B12 analysis in this study, the native B12 forms in the
samples were converted into their cyano forms by reacting them with a sufficient and tested
amount of NaCN (100 μL of 1% solution/sample) before the heat-extraction process (Study I).
Apart from the excellent retention of CNCbl, the pseudovitamin B12 present in a few samples
was also retained by the immunoaffinity column (Figure 10; Figure 13A). The affinity of
pseudovitamin B12 to the immunoaffinity antibodies, however, has not yet been tested, as
pseudovitamin B12 is not currently available commercially (Santos et al. 2007). Therefore, in
this study, we did not quantify the pseudovitamin B12 contents detected in the samples with
the UHPLC method. The MBA results likely reflect its level when the results are compared
with those obtained by the UHPLC method.
6.2 Ultra-high performance liquid chromatography–mass spectrometry confirms
the production of active B12 or its inactive form in whey-based medium and cereal
matrices by Propionibacteria
Several sample types were included to confirm the identification of the B12 compound, ranging
from a certified reference material (BCR 487 pig liver) which is known to contain active B12
to the cereal matrices fermented with P. freudenreichii, the cell biomasses of P. freudenreichii
and P. acidipropionici grown in WBM, and the baking samples with added B12 compounds or
B12 produced in situ in MEM with P. freudenreichii. As our study focused on the fortification
of food matrices with active B12, the accurate identification of the B12 form is necessary.
Consequently, UHPLC identification, based on the retention time and the PDA spectrum, was
further confirmed with MS. In the first two studies (Studies I, II), the confirmation was carried
out with the ion-trap MS. High-resolution QTOF MS allowed for the precise identification of
B12 compounds in cereal matrices fermented with strains of food-grade P. freudenreichii in
Study III.
Analysis with the ion-trap MS confirmed the production of active B12 forms, extracted as
CNCbl, in the experimental rye and barley malt matrices fermented with P. freudenreichii strain
266, similar to those identified in the reference material (BCR 487 pig liver). The CNCbl peak
showed mass spectra (Figure 11B) with fragments that confirmed the presence of DMBI in the
lower ligand (146 Da; [Mо1210]+)  when  the  ions  of  protonated  CNCbl  were  isolated  and
fragmented (Study I). MBA showed a B12 content of ca. 1200 ng/g in the concentrated malt
56
extract fermented with lactic and propionic acid bacteria (Table 6); however, the ion-trap
MS/MS did not detect any CNCbl in its immunoaffinity-purified B12 extract. Instead, the
fermented malt extract was confirmed to contain pseudovitamin B12 with adenine as the lower
ligand (Figures 10A and 11C), which possibly was measured as B12 by  MBA with the test
organism L. delbrueckii ATCC 7830, as seen in the study by Tanioka et al. (2009).
The ion-trap MS analysis of the cell extracts of representative strains from 30 PAB strains
(Table 3) grown in WBM with or without added precursor showed that all 27 P. freudenreichii
strains exclusively produced active B12 with DMBI as the lower ligand (Figure 12). The
analysis  of  the  cell  extracts  of  three P. acidipropionici strains confirmed that they did not
produce active B12 except when WBM was supplemented with DMBI. Without DMBI, a peak
seen at 3.16 min was identified as pseudovitamin B12 with the MS/MS mass spectra identical
to those found for the B12 compound detected in the lactic and propionic acid bacteria
fermented and concentrated malt extract (Figure 11B). Even with DMBI supplementation,
pseudovitamin B12 was still detected together with active B12.
After the confirmation that the P. freudenreichii strains produce active B12 in WBM (Study
II), we showed with the high-resolution QTOF MS that each of the three P. freudenreichii
strains (256, 263 and 266) also produced active B12 in the cereal matrices studied (Figure 13;
Study III). Unlike in the ion-trap MS, the analysis with QTOF MS allowed for the detection of
the molecular ions as well as the major fragment ions during the MS/MS procedure (Figure
13C), including the detection of the protonated DMBI fragment (m/z 147.0919). In BM and
AM with Co supplementation, a small peak confirmed as pseudovitamin B12 with adenine as
the lower ligand (m/z 136.0638) was observed. When sufficient in vivo DMBI synthesis was
not possible, a small level of pseudovitamin B12 is also produced by P. freudenreichii
(Vorobjeva 1999; Deptula et al. 2015). The synthesis of DMBI in PAB is species-dependent.
P. freudenreichii is capable of synthesising it from reduced FMN (Deptula et al. 2015), whereas
P. acidipropionici lacks the BluB/CobT2 fusion gene responsible for the synthesis  of  DMBI
(Parizzi  et  al.  2012).  The  synthesis  of  DMBI  by P. freudenreichii is dependent on the
availability of oxygen during growth, producing exclusively (but a small amount of)
pseudovitamin B12 when grown under complete anaerobic conditions (Deptula et al. 2015).
6.3 The ultra-high performance liquid chromatography method is more selective
than the microbiological assay for measuring active B12 in fermented food
matrices
The possibility of measuring only active B12 levels with the developed and validated UHPLC
method in a variety of samples studied (Studies I௅IV) demonstrates its superiority over MBA.
Except in Study II,  the  B12  contents  of  all  other  samples  were  measured  with  MBA  by
considering it as a reference method.  The B12 results determined with MBA for the cell
biomasses of P. freudenreichii strains grown in WBM (Tables 7 and 8) are also included in this
thesis, although they were not included in the original publications. In general, MBA showed
B12 contents that were identical to the results produced by the UHPLC method. However, for
certain samples, the B12 contents determined by MBA were higher than those obtained with
the UHPLC method.
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Identical B12 results obtained by the UHPLC method and by MBA for WBM with added DMBI
when fermented with P. freudenreichii strains (Table 7) indicate that the UHPLC method was
able to show that the synthesised compounds were the active B12 forms. Likewise, the similar
B12 yields by P. freudenreichii strains 256 and 266 in WBM with RF and NAM co-
supplementation given by the UHPLC and MBA methods (Table 8) suggest that P.
freudenreichii strains produce active B12 when a sufficient amount of the lower ligand
precursor is available. When DMBI or its natural precursors RF and NAM were supplemented
in cereal matrices with added Co, the identical results obtained in the matrices fermented with
P. freudenreichii strain 256 or 266 by both UHPLC and MBA (Figures 18 and 19) confirmed
that the availability of DMBI or RF and NAM ensures the production of active B12. Similar
results obtained by both methods for WBM without added Co (Table 8) show that P.
freudenreichii strains could use the RF available in the medium (2.5 μg/mL) for the biosynthesis
of DMBI required for the production of active B12 (0.19௅0.24 μg/mL).
However, the higher B12 contents in the 24-h fermented experimental rye and barley malt
matrices with P. freudenreichii 266 (33௅37%) (Table 6), and in BM and AM with Co
supplementation (20௅40%) (Figures 18 and 19) found by MBA compared to the UHPLC
method indicate that the matrices might contain inactive B12 analogues, such as pseudovitamin
B12 identified in fermented BM with added Co (Figure 13). When the synthesis of sufficient
DMBI is not possible, P. freudenreichii also produces a small amount of pseudovitamin B12 in
addition to active B12 (Vorobjeva 1999; Deptula et al. 2015). On the other hand, no differences
were found in the B12 contents in the dough and bread samples fortified with CNCbl or OHCbl
in the straight-dough and sponge-dough breadmaking methods. MBA gave higher B12 content
results than the UHPLC method did for some intermediate dough samples from the sourdough
process with added OHCbl (27%) or when fortified with in situ-produced B12 (19௅47%). The
results indicate that during the 16-h sourdough fermentation, lactic acid bacteria or P.
freudenreichii (with in situ-produced B12) might have synthesised B12 compounds other than
active B12, which were not accounted for in the UHPLC method but were included in the results
from MBA. Lactic acid bacteria such as L. reuteri are known to synthesise pseudovitamin B12
(Santos et al. 2007; Molina et al. 2009), which enables the growth of the assay organism used
in MBA (Herbert 1988; Ball 2006). In fact, only pseudovitamin B12 was detected in the
concentrated fermented malt extract sample (Table 3; Figure 3A) analysed in Study I in contrast
to a B12 content of approximately 1200 ng/g found via MBA.
In conclusion, MBA gives results that are equivalent to those determined by the UHPLC
method in food samples containing active B12 forms. Otherwise, it might result in B12 contents
greater than the results obtained with UHPLC. Therefore, for the fermented food materials that
likely contain inactive B12 analogues and/or other compounds promoting the growth of the
assay organism, MBA is not a suitable method for the measurement of active B12 contents.
Despite the poor specificity, MBA could still be used to analyse B12 contents in foods known
to contain active B12 and it does not require immunoaffinity purification. More sensitive and
specific analytical methods such as the developed UHPLC method allow for the accurate
quantitation of active B12 in fermented food materials intended for B12 fortification. Thus, the
B12 results presented and discussed in this thesis were based on the B12 contents obtained with
the UHPLC method.
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6.4 Active B12 production in whey-based medium and cereal matrices by
Propionibacterium freudenreichii
To the best of our knowledge, the use of P. freudenreichii in cereal matrices for B12 production
has not been reported previously. An active B12 production of 15.7௅19.3 ng/g in the
experimental rye and barley malt matrices by P. freudenreichii strain 266 within 24 h of
fermentation (Study I) indicated that PAB could be utilised for the natural B12 fortification of
cereal matrices. The increased B12 production (0.74௅0.93 μg/mL) in WBM with Co by strains
256 and 266 compared to the lower B12 yields (0.19௅0.24 μg/mL) without Co supplementation
(Table 8) showed that Co is one of the key factors regulating the ability of the strain to produce
B12. The produced B12 level in WBM with Co, however, was higher than the B12 yield (0.44
μg/mL) produced by P. freudenreichii DF13 in supplemented whey permeate for the same Co
addition level (Hugenschmidt et al. 2011). As discussed in the literature review, Co is inserted
in the early stage of B12 biosynthesis in PAB (Friedman and Cagen 1970; Moore and Warren
2012); its availability in the fermenting medium limits the level of B12 production (Bullerman
and Berry 1966; Hugenschmidt et al. 2011). Besides Co, DMBI is essential for the production
of active B12 (Martens et al. 2002; Crofts et al. 2013). In commercial B12 manufacturing,
DMBI is supplemented to increase B12 yields (Martens et al. 2002). For B12 production in
food matrices, DMBI should come from de novo synthesis. An enhanced active in situ B12
production in food matrices is thus possible only with strains synthesising DMBI in an efficient
manner. We, therefore, first studied 27 P. freudenreichii and 3 P. acidipropionici strains (Table
3) isolated from dairy and cereal environments for their active B12 production in WBM (Study
II) and then used 3 of the P. freudenreichii strains (256, 263 and 266) to study active B12
production in cereal matrices (Study III).
6.4.1 Active B12 production without supplementation of 5,6-dimethylbenzimidazole or its
precursors
The confirmation that all 27 P. freudenreichii strains studied produced active B12 in WBM
without DMBI supplementation clearly demonstrated that these food-grade strains synthesise
DMBI de novo for the production of active B12. A B12 yield ranging from 0.45 μg/mL to 3.45
μg/mL (Figure 14) suggests that the strains differed in their ability to synthesise B12. The yield
could have been affected by the growth (OD600 1.2௅17.8) (Figure 1A in Study II) and the final
pH of the medium (6.5௅4.7) (Figure 1B in Study II), because higher cellular B12 yields (Figure
17B) were observed for the strains growing to lower final OD600 values, with the final pH being
> 6 and producing smaller amounts of propionic and acetic acids (Supplemental Figure 1 in
Study II).
Earlier investigations have focused mostly on studying B12 production of natural strains with
added DMBI (Hugenschmidt et al. 2010) or in a pH-controlled fermentation (Bullerman and
Berry 1966; Marwaha et al. 1983; Quesada-Chanto, Schmid-Meyer, Schroeder, Fuchter, et al.
1998). In a pH-maintained (at 6.5) fermentation, the B12 yield of 2.7 μg/mL in corn-steep liquor
medium with the same type strain 282 (P. freudenreichii DSM 20271) used in the current study
(Quesada-Chanto et al. 1998b) was comparable to its production in WBM (2.5 μg/mL) without
the pH adjustment. The low-medium pH (< 6) is detrimental to growth and to B12 biosynthesis
in PAB (Hsu and Yang 1991; Vorobjeva 1999). The pH of the growth medium is, therefore,
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usually maintained at around 7 in industrial B12 production (Martens et al. 2002). However,
regulating medium pH nearer to a neutral value by adding an alkali agent is not practised in
food fermentation. The lower pH of the fermented products, instead, is beneficial for improving
the storage life of the products (Suomalainen and Mäyrä-Makinen 1999; Tinzl-Malang et al.
2015).
A good significant correlation between the B12 production and the corresponding depletion of
RF from the WBM (Figure 15) confirms that the DMBI part of the B12 was derived from RF.
The equivalent level of RF in WBM fermented by the P. acidipropionici strains and the control
medium corresponded with their inability to produce active B12 as these strains lack the DMBI-
synthesising gene, BluB/CobT2 (Parizzi et al. 2012). By studying several strains originating
from different environments, these results further confirm the current understanding that flavin
compounds are the substrates for DMBI biosynthesis in P. freudenreichii (Renz and
Weyhenmeyer 1972; Hörig and Renz 1977; Deptula et al. 2015).
P. freudenreichii strains 256, 263 and 266, which varied in B12 production in WBM (0.73௅
1.80 μg/mL), were investigated for B12 production in the cereal matrices (Study III).
Compared to the higher B12 yields in WBM which contained added Co, the B12 production
with these strains in the cereal matrices supplemented with Co was lower (Figures 18 and 19).
Among the cereal matrices, the highest level of B12 (430 ng/g) was produced in BM with added
Co by P. freudenreichii strain 256. Apart from the other differences in medium composition
between WBM and BM that might have influenced the B12 production, the WBM was buffered
with 0.1 M potassium phosphate with a higher initial pH (6.4) compared to unbuffered BM with
an initial pH of 5.6. Through Co supplementation, AM allowed for production of up to 114 ng/g
by strain 266 whereas 39 ng/g was produced by strain 256 in BF. Still the produced level in the
cereal matrices by strains 256, 263 and 266 was lower than the yield obtained in MEM (0.69
μg/mL) by P. freudenreichii 282 (type strain). MEM was a buffered medium (pH 6.4) and it
was supplemented with yeast extract and a protein source (tryptone). In addition, the
considerably higher level of RF in WBM (2.5 μg/mL) compared to the RF contents in the cereal
matrices (estimated levels: 0.03௅0.5 μg/g) may also explain the higher B12 yields in WBM.
Although evaluation of the B12 produced in the studied cereal matrices by P. freudenreichii
strains with literature values is not possible due to the lack of related studies, the B12 contents
achieved in the fermented matrices, however, can be compared with the values reported for
other fermented plant-based foods. A good amount of B12 was found in sauerkraut (70 ng/g)
prepared with a Propionibacterium jensenii strain compared to 20 ng/g in the control sauerkraut
(Babuchowski et al. 1999). As B12 was analysed with MBA using L. delbrueckii ATCC 7830,
the actual level of active B12 could be different. The reported B12 contained in tempeh varies
considerably ranging from 1.6 ng/g to 80 ng/g (Mo et al. 2013; Watanabe et al. 2013),
influenced by the fermentation process (Denter and Bisping 1994) and type of tempeh cultures
used (Keuth and Bisping 1994). Gu et al. (2015) reported B12 content of 180 ng/mL in soy
yoghurt prepared with L. reuteri strain ZJ03, which was also measured with MBA.
In the cereal matrices, the active B12 production of 9௅37 ng/g (i.e. 0.9௅3.7 μg/100 g) achieved
without any supplementation (Figures 18 and 19) by fermenting with P. freudenreichii strains
is already nutritionally relevant when considering the RDA value for B12 of 2௅2.4 μg/day for
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adults (Institute of Medicine 1998; Nordic Nutrition Recommendations 2012 2013). The
difference in B12 production between the matrices was expected as BM contained the greatest
proportion of flour (33% w/v) compared to 15% w/v in AM and 6% w/v in BF. Cereals and
cereal fractions differ in the natural amount of Co they contain (Varo et al. 1980; Ekholm et al.
2007; Kabata-Pendias and Mukherjee 2007), with the Co content found to be higher in whole
grain flours and their bran fractions. Also, the RF contents of the flours used in these matrices
differed, with malted barley flour containing 2.3 μg/g in comparison to 3.1 μg/g in wheat
aleurone and 0.5 μg/g in barley flour. Besides, the higher level of fermentable sugars in BM
was reflected in the better growth of P. freudenreichii strains in BM than in the other two
matrices (Table 1 in Study III). The current level of in situ B12 production in cereal matrices
can further be improved by using cereal materials rich in natural Co content, e.g. certain
Australian or Egyptian wheats (Kabata-Pendias and Mukherjee 2007) or cereal fractions that
are normally higher in Co and RF contents, and by further optimising the composition of the
matrices.
6.4.2 Potential to increase B12 production by co-supplementation with riboflavin and
nicotinamide
Unlike RF and NAM supplementation on day 6 similar to what is practised for DMBI addition
in commercial production, our study showed that an early addition of RF and NAM (on day 0
or day 3) was more effective at increasing B12 production in certain P. freudenreichii strains
(Figure 16). As RF and niacin found in food matrices are available from the beginning of the
fermentation and early availability of these vitamins is beneficial, this important finding could
be exploited to improve in situ B12 production with P. freudenreichii. In contrast, early
supplementation of DMBI was reported to decrease the B12 yield (Marwaha et al. 1983) and
its addition at the late stage of fermentation is a common practice in industrial B12 production
(Martens et al. 2002).
In general, the growth of the strains in both WBM (Figure 1A in Study II) and in cereal matrices
(Figure 1 in Study III) was not affected by supplementation. The similar growth rates mean
that the increased B12 production was dependent on the type of supplement. The results from
Study II showed that B12 production by certain P. freudenreichii strains could be significantly
increased by co-supplementation with RF and NAM. The addition of RF alone did not increase
the B12 production in WBM by any of the strains; its co-supplementation with NAM, however,
increased the volumetric B12 yields up to 4-fold with 12 of the 27 P. freudenreichii strains
studied (Figure 17A). Interestingly, for some strains the co-addition of RF and NAM was more
effective at enhancing the B12 yield than DMBI was, suggesting that added DMBI was not
beneficial in terms of enhancing B12 production in WBM. Instead, the natural precursors (RF
and  NAM)  may  be  more  suitable  for  increasing in situ B12 production with a strain that
responds to them. An enhanced B12 production in cereal matrices was also obtained by co-
supplementation with RF and NAM (Figures 18 and 19) compared to the production without
these food-grade DMBI precursors. For example, supplementation with RF and NAM in BM
increased the B12 yield with P. freudenreichii strain 256 from 430 ng/g to 716 ng/g and from
112 ng/g to 627 ng/g with strain 266. The enhancing effect of RF and NAM on B12 production
was also found in AM, thus improving the active B12 contents in the fermented AM. The lower
yields with RF and NAM supplementation compared to B12 production with DMBI
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supplementation in BM (975௅1480 ng/g) could be due to the low pH affecting the de novo
biosynthesis of DMBI, which needs to be investigated in further studies.
The B12 production in WBM with RF and NAM co-supplementation by some of the strains in
this study was higher than the yields reported for 100 natural PAB strains in supplemented whey
permeate with DMBI supplementation (Hugenschmidt et al. 2010). The maximum B12 yield
obtained on screening the large number of PAB strains was 2.5 μg/mL (Hugenschmidt et al.
2010). P. freudenreichii strain 288 with DMBI supplementation produced approximately 2-fold
the reported yield (5.3 μg/mL). A maximum B12 yield of 4.2 μg/mL was achieved with a P.
freudenreichii strain (284) with RF and NAM co-supplementation.
In this study, we demonstrated with live P. freudenreichii cells that an improved production of
active B12 in WBM as well as in cereal matrices was possible through co-supplementation with
RF and NAM. The increased production was likely due to the enhanced DMBI biosynthesis
and its activation into the nucleotide, thus being ready for incorporation to complete the
biosynthesis of active B12. This important finding in our study confirms the earlier observation
in cell homogenates of P. freudenreichii that DMBI biosynthesis was stimulated by 27 mM
NAM incubated under aerobic conditions (Hörig and Renz 1980). The added NAM was found
to be converted into NA, as was found in the study by Hörig and Renz (1980), confirming NA
as the actual stimulant of DMBI biosynthesis in P. freudenreichii. The exact mechanism behind
this stimulation is not known. It is hypothesised that NA or its coenzyme form NaMN might
allosterically regulate the DMBI-synthesising BluB/CobT2 enzyme (Chen et al. 1995).
Additionally, sufficient availability of NA could be utilised for an enhanced biosynthesis of
NaMN, which is involved in the activation of DMBI into Į-ribazole phosphate so that it is ready
for incorporation into the incomplete adenosylcobinamide (Friedmann and Harris 1965;
Deptula et al. 2015).
6.5 In situ-produced B12 is stable during breadmaking
Bread is an attractive food to fortify with B12. Knowledge regarding its stability during various
breadmaking processes, however, is limited. Only wheat bread fortified with CNCbl has been
studied so far. In this study, we investigated the retention of in situ-produced B12 during
straight-dough and sourdough breadmaking as compared to that of added CNCbl and OHCbl.
In addition, the stability of the added compounds was also investigated during sponge-dough
baking.
The added CNCbl remained protected in the straight-dough and sponge-dough processes, while
the initial level of OHCbl decreased during breadmaking for both processes (by 21% and 31%,
respectively) (Figure 20). The sponge-dough method differs from the straight-dough method
due to a 1.5-h pre-proofing step; the higher loss of OHCbl in sponge-dough baking could be
attributed to the pre-proofing stage. Unlike the significant loss of supplemented OHCbl (Figure
13B), the in situ-produced B12 remained stable (at both levels; 114 ng/g dm and 466 ng/g dm)
similarly to CNCbl in the straight-dough breadmaking process (Figures 20A and 21).
Compared to the retention of added CNCbl and in situ-produced B12 in the straight-dough
method of breadmaking, the sourdough process, however, caused a loss of 23% of the added
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CNCbl content and 29% of in situ-produced B12 (Figures 20C, 20D and 22). OHCbl destruction
increased by 2-fold (44%) in sourdough breadmaking compared to its loss during the straight-
dough process (21%). Due to the dilution of the B12 contents in the dough by the addition of
the remaining flour, the losses in the sourdough breadmaking were compared separately before
and after the 16-h fermentation. The results clearly showed that the destruction of B12 happened
during the longer baking step of the sourdough process (70 min) compared to no loss of vitamins
(except for a 21% loss of OHCbl) in the shorter baking period in straight-dough breadmaking
(20 min).
As pointed out earlier (Section 2.9), the retention of B12 during processing has been studied
mostly in animal-based foods. In breadmaking, only the straight-dough process has been
studied for the retention of fortified CNCbl (Czernichow et al. 2003; Winkels et al. 2008).
Contrary to 19௅23% losses found by Winkels et al. (2008) and 45% losses reported by
Czernichow et al. (2003) during the preparation of wheat bread, added CNCbl was found to be
stable in the straight-dough breadmaking process in our study. The higher destruction of added
OHCbl in the baking processes agrees with the considerable losses reported for B12 contents
in animal-based products. Losses were as high as 22௅49% when cooking, roasting or grilling
of beef (Bennink and Ono 1982; Czerwonka et al. 2014), 30௅40% when microwaving beef,
pork and milk (Watanabe et al. 1998) and 41௅59% in typical grilling, boiling, steaming and
microwaving of herring (Nishioka et al. 2011). In agreement with these studies, the lower
stability  of  CNCbl  or in situ-produced B12 in the sourdough process could be the result of
baking for a longer duration at a higher temperature. Besides, the drop in pH (from 6.4 to 3.8)
during the sourdough fermentation could have affected the stability of the B12 compounds, in
addition to the possible destabilisation due to reactive compounds (e.g. RF and NAM) and
reducing agents such as ascorbic acid (Ahmad et al. 2003; Ahmad 2012; Juzeniene and
Nizauskaite 2013; Ahmad et al. 2014).
Overall, the active B12 incorporated in dough using the fermented MEM during breadmaking
was more stable than the added OHCbl and it was retained comparably to CNCbl, which is
regarded as the most stable B12 form. As the B12 is accumulated in cells during the
biosynthesis of B12 in P. freudenreichii (Martens et al. 2002; Warren et al. 2002), native forms
are likely protected, to some extent, from the exposure to light, heat and pH compared to the
added pure compounds. The better retention could be due to the higher pH of the final dough
(approximately 5) in in situ-produced B12 compared to a pH of approximately 3.8௅4.2 in the
sourdough with the added compounds (Table 2 in Study IV). Nevertheless, the level of B12
retained in the breads (0.23 μg/g fw) prepared from the MEM fermented with P. freudenreichii
strain 282 was 3-fold the RDA when simply consuming one slice of the bread (30 g). The focus
of this study was to understand the stability of microbiologically produced active B12 during
baking processes, the B12 content, and the baking and sensory quality of the breads, however,
can be further adjusted by optimising the composition of the MEM medium and the
fermentation conditions.
7 Conclusions
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7 Conclusions
Plant-based foods do not contain B12, which means vegetarians, vegans and people who cannot
afford animal-based products or those who do not consume meat for various reasons are
generally at higher risk of B12 deficiency globally. In addition, the current recommendation
emphasises reducing meat consumption by increasing plant proteins in the diet. The focus of
this study was to explore the potential of in situ production of active B12 in food matrices using
strains of food-grade P. freudenreichii to fortify foods with B12 naturally. Another primary
objective was to develop sensitive and selective methods to analyse active B12 accurately in
the fermented products.
The developed and validated UHPLC method with UV/Vis detection allows for a clear
separation and sensitive quantitation of active B12 in fermented cereal matrices and baking
samples fortified with added or in situ-produced B12 after purification on immunoaffinity
columns. The determination of active B12 content in cell biomasses of PAB with the UHPLC
method does not require immunoaffinity sample purification. Analysis with an ion-trap or high-
resolution QTOF mass spectrometer confirmed production of active B12 in WBM and cereal
matrices by P. freudenreichii, whereas P. acidipropionici strains  (studied  only  in  WBM)
produced pseudovitamin B12 unless supplemented with DMBI. MBA usually gave B12
contents higher than those obtained with the UHPLC method, showing that the measurement
of active B12 in fermented foods with MBA needs additional confirmation with more specific
methods, such as UHPLC.
The considerable variation in B12 yields in WBM (0.45௅3.35 μg/mL) by the 27 P.
freudenreichii strains and their varied response to supplementation with DMBI or its food-grade
precursors RF and NAM on enhancing B12 production showed that the efficiency of B12
biosynthesis in P. freudenreichii is strain-dependent. Among 27 P. freudenreichii strains, 12 of
them produced more active B12 (up to 4-fold) with RF and NAM co-supplementation,
sometimes even exceeding the yields obtained with DMBI addition. The highest B12 yield
achieved in WBM with RF and NAM co-supplementation was 4.2 μg/mL. The significant
positive correlation between RF consumption and B12 production in WBM clearly shows that
DMBI is synthesised from RF and guided to B12 biosynthesis. When RF and NAM were co-
added to BM and AM supplemented with Co, the B12 production by the three studied P.
freudenreichii strains increased up to 5.5-fold. These results confirmed that RF and NAM are
capable of increasing active B12 production in food matrices where the use of DMBI is not
possible.
The active B12 produced in three cereal matrices (BM, BF and AM) without any
supplementation ranged from 9 ng to 37 ng /g (or 0.9௅3.7 μg/100 g); the B12 levels produced
in  these  matrices  can  easily  fulfil  the  RDA  of  2௅2.4  μg/day  (for  adults).  Already  in  WBM
without Co addition, the produced level is nutritionally relevant (190௅240 ng/mL). With food-
grade RF and NAM co-supplementation, the production of active B12 in the cereal matrices
was shown to increase many-fold, reaching approximately to 700 ng/g with the studied P.
freudenreichii strains. B12 produced in situ in MEM by P. freudenreichii was found to be as
stable as the chemically modified CNCbl during commonly used breadmaking processes
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(straight-dough, sponge-dough and sourdough), being retained in the final product better than
the added OHCbl.
In conclusion, this study showed that P. freudenreichii can be used for the natural fortification
of active B12 in plant-based foods and that UHPLC–UV–MS methods are reliable analytical
tools for ensuring the determination of active B12 in fermented foods. Further studies could
focus on optimising the composition of the cereal matrices (for the levels of sugars, Co, RF and
NAM) to increase active B12 production with P. freudenreichii strains.
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